a need to simplify informed consent documents in cancer ... · a need to simplify informed consent...
TRANSCRIPT
A need to simplify informed consent documents in cancer clinical trials. A position paper of
the ARCAD Group.
Bleiberg H, Decoster G, de Gramont A, Rougier P, Sobrero A, Benson A, Chibaudel B,
Douillard JY, Eng C, Fuchs C, Fujii M, Labianca R, Larsen AK, Mitchell E, Schmoll HJ,
Sprumont D, Zalcberg J.
Ann Oncol. 2017 Feb 13. doi: 10.1093/annonc/mdx050. [Epub ahead of print] No abstract
available.
PMID:
28200006
Similar articles
Select item 28081228 2.
Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia
but Not Generally Dependent on p53-Regulated Cell Cycle Arrest.
Lützkendorf J, Wieduwild E, Nerger K, Lambrecht N, Schmoll HJ, Müller-Tidow C, Müller
LP.
PLoS One. 2017 Jan 12;12(1):e0169921. doi: 10.1371/journal.pone.0169921. eCollection
2017.
PMID:
28081228
Free PMC Article
Similar articles
Select item 27843641 3.
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition
2016.
Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P,
Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F,
Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de
Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J,
Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C,
Herrstedt J, Homicsko K, Jones DV Jr, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH,
Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham
MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G,
Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C,
Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E,
Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN,
Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes
E, Von Roenn J, Weber JS, Wildiers H, Yarden Y.
ESMO Open. 2016 Sep 29;1(5):e000097. eCollection 2016. Review.
PMID:
27843641
Free PMC Article
Similar articles
Select item 27753609 4.
Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance
therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK
0207 trial.
Quidde J, Hegewisch-Becker S, Graeven U, Lerchenmüller CA, Killing B, Depenbusch R,
Steffens CC, Lange T, Dietrich G, Stoehlmacher J, Reinacher A, Tannapfel A, Trarbach T,
Marschner N, Schmoll HJ, Hinke A, Al-Batran SE, Arnold D.
Ann Oncol. 2016 Dec;27(12):2203-2210. doi: 10.1093/annonc/mdw425. Epub 2016 Oct 17.
PMID:
27753609
Similar articles
Select item 27681944 5.
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a
randomised phase II/III trial.
Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY,
Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frodin JE, Ayers M, Nebozhyn M,
Peckitt C, Loboda A, Watkins DJ.
Int J Cancer. 2017 Jan 15;140(2):431-439. doi: 10.1002/ijc.30453. Epub 2016 Oct 17.
PMID:
27681944
Similar articles
Select item 27717654 6.
Corrigendum to "2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus
recommendations on controversial issues in the primary treatment of rectal cancer" [Eur J
Cancer 63 (August 2016) 11-24].
Lutz MP, Zalcberg JR, Glynne-Jones R, Ruers T, Ducreux M, Arnold D, Aust D, Brown G,
Bujko K, Cunningham C, Evrard S, Folprecht G, Gerard JP, Habr-Gama A, Haustermans K,
Holm T, Kuhlmann KF, Lordick F, Mentha G, Moehler M, Nagtegaal ID, Pigazzi A,
Pucciarelli S, Roth A, Rutten H, Schmoll HJ, Sorbye H, Van Cutsem E, Weitz J, Otto F.
Eur J Cancer. 2016 Nov;68:208-209. doi: 10.1016/j.ejca.2016.08.017. Epub 2016 Oct 4. No
abstract available.
PMID:
27717654
Free Article
Similar articles
Select item 27582078 7.
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced
adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase
II AIO trial with serum biomarker program.
Moehler M, Gepfner-Tuma I, Maderer A, Thuss-Patience PC, Ruessel J, Hegewisch-Becker
S, Wilke H, Al-Batran SE, Rafiyan MR, Weißinger F, Schmoll HJ, Kullmann F, von
Weikersthal LF, Siveke JT, Weusmann J, Kanzler S, Schimanski CC, Otte M, Schollenberger
L, Koenig J, Galle PR.
BMC Cancer. 2016 Aug 31;16:699. doi: 10.1186/s12885-016-2736-9.
PMID:
27582078
Free PMC Article
Similar articles
Select item 27468630 8.
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967
patients from the ACCENT database.
Papamichael D, Renfro LA, Matthaiou C, Yothers G, Saltz L, Guthrie KA, Van Cutsem E,
Schmoll HJ, Labianca R, André T, O'Connell M, Alberts SR, Haller DG, Kountourakis P,
Sargent DJ; Adjuvant Colon Cancer Endpoints (ACCENT) Group..
J Geriatr Oncol. 2016 Nov;7(6):422-429. doi: 10.1016/j.jgo.2016.07.002. Epub 2016 Jul 25.
PMID:
27468630
Free PMC Article
Similar articles
Select item 27457308 9.
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition
2016.
Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El Saghir N, Lotz JP, Österlund P,
Pavlidis N, Purkalne G; ESMO/ASCO Global Curriculum Working Group..
Ann Oncol. 2016 Aug;27(8):1378-81. doi: 10.1093/annonc/mdw239. No abstract available.
PMID:
27457308
Free PMC Article
Similar articles
Select item 27397855 10.
MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial.
Gormly KL, Coscia C, Wells T, Tebbutt N, Harvey JA, Wilson K, Schmoll HJ, Price T.
J Med Imaging Radiat Oncol. 2016 Oct;60(5):607-615. doi: 10.1111/1754-9485.12493. Epub
2016 Jul 11.
PMID:
27397855
Similar articles
Select item 27380959 11.
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda
Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E,
Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K,
Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K,
Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ,
Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar
S, Wasan H, Yoshino T, Zaanan A, Arnold D.
Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.
PMID:
27380959
Similar articles
Select item 27358379 12.
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation
variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO
colorectal cancer study group.
Modest DP, Ricard I, Heinemann V, Hegewisch-Becker S, Schmiegel W, Porschen R,
Stintzing S, Graeven U, Arnold D, von Weikersthal LF, Giessen-Jung C, Stahler A, Schmoll
HJ, Jung A, Kirchner T, Tannapfel A, Reinacher-Schick A.
Ann Oncol. 2016 Sep;27(9):1746-53. doi: 10.1093/annonc/mdw261. Epub 2016 Jun 29.
PMID:
27358379
Free PMC Article
Similar articles
Select item 27254838 13.
Second St. Gallen European Organisation for Research and Treatment of Cancer
Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in
the primary treatment of rectal cancer.
Lutz MP, Zalcberg JR, Glynne-Jones R, Ruers T, Ducreux M, Arnold D, Aust D, Brown G,
Bujko K, Cunningham C, Evrard S, Folprecht G, Gerard JP, Habr-Gama A, Haustermans K,
Holm T, Kuhlmann KF, Lordick F, Mentha G, Moehler M, Nagtegaal ID, Pigazzi A,
Puciarelli S, Roth A, Rutten H, Schmoll HJ, Sorbye H, Van Cutsem E, Weitz J, Otto F.
Eur J Cancer. 2016 Aug;63:11-24. doi: 10.1016/j.ejca.2016.04.010. Epub 2016 May 30.
Review.
PMID:
27254838
Free Article
Similar articles
Select item 27132696 14.
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix
regimen) in patients with primary CNS lymphoma: results of the first randomisation of the
International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP,
Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R,
Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F,
Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli
F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group
(IELSG)..
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016
Apr 6.
PMID:
27132696
Similar articles
Select item 27108244 15.
Targeting HER2: precision oncology for colorectal cancer.
Schmoll HJ.
Lancet Oncol. 2016 Jun;17(6):685-6. doi: 10.1016/S1470-2045(16)30039-0. Epub 2016 Apr
20. No abstract available.
PMID:
27108244
Similar articles
Select item 26857103 16.
Interdisciplinary care programme to improve self-management for cancer patients undergoing
stem cell transplantation: a prospective non-randomised intervention study.
Schmidt H, Boese S, Bauer A, Landenberger M, Lau A, Stoll O, Schmoll HJ, Mauz-Koerholz
C, Kuss O, Jahn P.
Eur J Cancer Care (Engl). 2016 Feb 9. doi: 10.1111/ecc.12458. [Epub ahead of print]
PMID:
26857103
Similar articles
Select item 26811529 17.
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in
Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant
Colon Cancer End Points (ACCENT) Database.
Shah MA, Renfro LA, Allegra CJ, André T, de Gramont A, Schmoll HJ, Haller DG, Alberts
SR, Yothers G, Sargent DJ.
J Clin Oncol. 2016 Mar 10;34(8):843-53. doi: 10.1200/JCO.2015.63.0558. Epub 2016 Jan 25.
PMID:
26811529
Free PMC Article
Similar articles
Select item 26706237 18.
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal
Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to
Exclusion of Patients who had Recurrence During or Within 6 Months of Completing
Adjuvant Oxaliplatin-Based Therapy.
Van Cutsem E, Joulain F, Hoff PM, Mitchell E, Ruff P, Lakomý R, Prausová J, Moiseyenko
VM, van Hazel G, Cunningham D, Arnold D, Schmoll HJ, Ten Tije AJ, McKendrick J,
Kröning H, Humblet Y, Grávalos C, Le-Guennec S, Andria M, Dochy E, Vishwanath RL,
Macarulla T, Tabernero J.
Target Oncol. 2016 Jun;11(3):383-400. doi: 10.1007/s11523-015-0402-9.
PMID:
26706237
Similar articles
Select item 26694748 19.
Trans-sectoral care in patients with colorectal cancer: Protocol of the randomized controlled
multi-center trial Supportive Cancer Care Networkers (SCAN).
Bauer A, Vordermark D, Seufferlein T, Schmoll HJ, Dralle H, Mau W, Unverzagt S, Boese S,
Fach EM, Landenberger M.
BMC Cancer. 2015 Dec 22;15:997. doi: 10.1186/s12885-015-2002-6.
PMID:
26694748
Free PMC Article
Similar articles
Select item 26503203 20.
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients
From First-Line Clinical Trials in the ARCAD Database.
Renfro LA, Loupakis F, Adams RA, Seymour MT, Heinemann V, Schmoll HJ, Douillard JY,
Hurwitz H, Fuchs CS, Diaz-Rubio E, Porschen R, Tournigand C, Chibaudel B, Falcone A,
Tebbutt NC, Punt CJ, Hecht JR, Bokemeyer C, Van Cutsem E, Goldberg RM, Saltz LB, de
Gramont A, Sargent DJ, Lenz HJ.
J Clin Oncol. 2016 Jan 10;34(2):144-50. doi: 10.1200/JCO.2015.61.6441. Epub 2015 Oct 26.
PMID:
26503203
Free PMC Article
Similar articles
21.
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and
Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.
Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY,
Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frödin JE, Ayers M, Nebozhyn M,
Peckitt C, Loboda A, Mauro DJ, Watkins DJ.
J Natl Cancer Inst. 2015 Sep 23;107(12):djv258. doi: 10.1093/jnci/djv258. Print 2015 Dec.
PMID:
26405092
Similar articles
Select item 26361971 22.
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for
patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-
label, phase 3 trial.
Hegewisch-Becker S, Graeven U, Lerchenmüller CA, Killing B, Depenbusch R, Steffens CC,
Al-Batran SE, Lange T, Dietrich G, Stoehlmacher J, Tannapfel A, Reinacher-Schick A,
Quidde J, Trarbach T, Hinke A, Schmoll HJ, Arnold D.
Lancet Oncol. 2015 Oct;16(13):1355-69. doi: 10.1016/S1470-2045(15)00042-X. Epub 2015
Sep 8. Erratum in: Lancet Oncol. 2015 Dec;16(16):e589.
PMID:
26361971
Similar articles
Select item 26356035 23.
Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer
cells by a β1-integrin-dependent mechanism.
Widder M, Lützkendorf J, Caysa H, Unverzagt S, Wickenhauser C, Benndorf RA, Schmoll
HJ, Müller-Tidow C, Müller T, Müller LP.
Int J Cancer. 2016 Feb 15;138(4):964-75. doi: 10.1002/ijc.29844. Epub 2015 Oct 1.
PMID:
26356035
Free Article
Similar articles
Select item 26324362 24.
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant
Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled
Phase III Trial.
Schmoll HJ, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Hoersch S,
Rittweger K, Haller DG.
J Clin Oncol. 2015 Nov 10;33(32):3733-40. doi: 10.1200/JCO.2015.60.9107. Epub 2015 Aug
31.
PMID:
26324362
Similar articles
Select item 26271204 25.
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in
Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.
van den Berg H, Paulussen M, Le Teuff G, Judson I, Gelderblom H, Dirksen U, Brennan B,
Whelan J, Ladenstein RL, Marec-Berard P, Kruseova J, Hjorth L, Kühne T, Brichard B,
Wheatley K, Craft A, Juergens H, Gaspar N, Le Deley MC; Euro-EWING99 Group..
Eur J Cancer. 2015 Nov;51(16):2453-64. doi: 10.1016/j.ejca.2015.06.123. Epub 2015 Aug 10.
PMID:
26271204
Similar articles
Select item 26087013 26.
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in
BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
Haaß W, Kleiner H, Weiß C, Haferlach C, Schlegelberger B, Müller MC, Hehlmann R,
Hofmann WK, Fabarius A, Seifarth W; Schweizerische Arbeitsgemeinschaft für Klinische
Krebsforschung.; German CML Study Group..
PLoS One. 2015 Jun 18;10(6):e0129648. doi: 10.1371/journal.pone.0129648. eCollection
2015.
PMID:
26087013
Free PMC Article
Similar articles
Select item 25795636 27.
Aprepitant and fosaprepitant: a 10-year review of efficacy and safety.
Aapro M, Carides A, Rapoport BL, Schmoll HJ, Zhang L, Warr D.
Oncologist. 2015 Apr;20(4):450-8. doi: 10.1634/theoncologist.2014-0229. Epub 2015 Mar
20. Review.
PMID:
25795636
Free PMC Article
Similar articles
Select item 25791073 28.
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
Jahn F, Jordan K, Behlendorf T, Globig C, Schmoll HJ, Müller-Tidow C, Jordan B.
Oncology. 2015;89(3):137-42. doi: 10.1159/000380913. Epub 2015 Mar 18.
PMID:
25791073
Similar articles
Select item 25697217 29.
Survival following early-stage colon cancer: an ACCENT-based comparison of patients
versus a matched international general population†.
Renfro LA, Grothey A, Kerr D, Haller DG, André T, Van Cutsem E, Saltz L, Labianca R,
Loprinzi CL, Alberts SR, Schmoll H, Twelves C, Yothers G, Sargent DJ; Adjuvant Colon
Cancer Endpoints (ACCENT) Group.; Adjuvant Colon Cancer Endpoints ACCENT Group..
Ann Oncol. 2015 May;26(5):950-8. doi: 10.1093/annonc/mdv073. Epub 2015 Feb 19.
PMID:
25697217
Free PMC Article
Similar articles
Select item 25692824 30.
Cooperative learning using simulation to achieve mastery of nasogastric tube insertion.
Cason ML, Gilbert GE, Schmoll HH, Dolinar SM, Anderson J, Nickles BM, Pufpaff LA,
Henderson R, Lee FW, Schaefer JJ 3rd.
J Nurs Educ. 2015 Mar;54(3 Suppl):S47-51. doi: 10.3928/01484834-20150218-09. Epub
2015 Feb 20.
PMID:
25692824
Similar articles
Select item 25595934 31.
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon
cancer: a pooled analysis of individual patient data from four randomized, controlled trials.
Haller DG, O'Connell MJ, Cartwright TH, Twelves CJ, McKenna EF, Sun W, Saif MW, Lee
S, Yothers G, Schmoll HJ.
Ann Oncol. 2015 Apr;26(4):715-24. doi: 10.1093/annonc/mdv003. Epub 2015 Jan 16.
PMID:
25595934
Free PMC Article
Similar articles
Select item 25579803 32.
A review of the evolution of systemic chemotherapy in the management of colorectal cancer.
Gustavsson B, Carlsson G, Machover D, Petrelli N, Roth A, Schmoll HJ, Tveit KM, Gibson
F.
Clin Colorectal Cancer. 2015 Mar;14(1):1-10. doi: 10.1016/j.clcc.2014.11.002. Epub 2014
Nov 15. Review.
PMID:
25579803
Free Article
Similar articles
Select item 25577571 33.
MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: from bench to
bedside.
Wittig B, Schmidt M, Scheithauer W, Schmoll HJ.
Crit Rev Oncol Hematol. 2015 Apr;94(1):31-44. doi: 10.1016/j.critrevonc.2014.12.002. Epub
2014 Dec 19. Review.
PMID:
25577571
Free Article
Similar articles
Select item 25527417 34.
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab
refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck
(SCCHN) of the German SCCHN Group (AIO).
Grünwald V, Keilholz U, Boehm A, Guntinas-Lichius O, Hennemann B, Schmoll HJ, Ivanyi
P, Abbas M, Lehmann U, Koch A, Karch A, Zörner A, Gauler TC.
Ann Oncol. 2015 Mar;26(3):561-7. doi: 10.1093/annonc/mdu571. Epub 2014 Dec 19.
PMID:
25527417
Similar articles
Select item 25466509 35.
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients
with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.
Ruff P, Ferry DR, Lakomỳ R, Prausová J, Van Hazel GA, Hoff PM, Cunningham D, Arnold
D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, Ten Tije AJ, Vishwanath RL, Bhargava P,
Chevalier S, Macarulla T, Van Cutsem E.
Eur J Cancer. 2015 Jan;51(1):18-26. doi: 10.1016/j.ejca.2014.10.019. Epub 2014 Nov 14.
PMID:
25466509
Free Article
Similar articles
Select item 25456367 36.
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival
outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a
pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ, Twelves C, Sun W, O'Connell MJ, Cartwright T, McKenna E, Saif M, Lee S,
Yothers G, Haller D.
Lancet Oncol. 2014 Dec;15(13):1481-92. doi: 10.1016/S1470-2045(14)70486-3. Epub 2014
Nov 12.
PMID:
25456367
Free PMC Article
Similar articles
Select item 25385741 37.
Individual patient data analysis of progression-free survival versus overall survival as a first-
line end point for metastatic colorectal cancer in modern randomized trials: findings from the
analysis and research in cancers of the digestive system database.
Shi Q, de Gramont A, Grothey A, Zalcberg J, Chibaudel B, Schmoll HJ, Seymour MT,
Adams R, Saltz L, Goldberg RM, Punt CJ, Douillard JY, Hoff PM, Hecht JR, Hurwitz H,
Díaz-Rubio E, Porschen R, Tebbutt NC, Fuchs C, Souglakos J, Falcone A, Tournigand C,
Kabbinavar FF, Heinemann V, Van Cutsem E, Bokemeyer C, Buyse M, Sargent DJ.
J Clin Oncol. 2015 Jan 1;33(1):22-8. doi: 10.1200/JCO.2014.56.5887. Epub 2014 Nov 10.
PMID:
25385741
Free PMC Article
Similar articles
Select item 25294886 38.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the
PETACC8 phase III trial dataset.
Blons H, Emile JF, Le Malicot K, Julié C, Zaanan A, Tabernero J, Mini E, Folprecht G, Van
Laethem JL, Thaler J, Bridgewater J, Nørgård-Petersen L, Van Cutsem E, Lepage C, Zawadi
MA, Salazar R, Laurent-Puig P, Taieb J; PETACC-8 Study Investigators..
Ann Oncol. 2014 Dec;25(12):2378-85. doi: 10.1093/annonc/mdu464. Epub 2014 Oct 6.
Erratum in: Ann Oncol. 2015 Apr;26(4):822-5.
PMID:
25294886
Similar articles
Select item 25195828 39.
Benefits and risks of colorectal cancer screening.
Riemann JF, Schröder C, Kallenbach M, Giersiepen K, Schmoll HJ.
Oncol Res Treat. 2014;37 Suppl 3:11-20. doi: 10.1159/000364886. Epub 2014 Aug 29. No
abstract available.
PMID:
25195828
Similar articles
Select item 25001888 40.
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard
BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Huddart RA, Gabe R, Cafferty FH, Pollock P, White JD, Shamash J, Cullen MH, Stenning
SP; TE23 Trial Management Group and Collaborators.; National Cancer Research Institute
Testis Cancer Clinical Studies Group..
Eur Urol. 2015 Mar;67(3):534-43. doi: 10.1016/j.eururo.2014.06.034. Epub 2014 Jul 4.
PMID:
25001888
Free PMC Article
Similar articles
41.
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected
stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J,
Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF,
Laurent-Puig P, Lepage C; PETACC-8 Study Investigators..
Lancet Oncol. 2014 Jul;15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun
11.
PMID:
24928083
Similar articles
Select item 24903762 42.
Best supportive care from the conservative/non-surgical perspective and its costs in the
treatment of patients with advanced medullary thyroid cancer: results of a Delphi panel.
Kreissl MC, Jacob C, Führer D, Karges W, Luster M, Lux MP, Mann K, Mittendorf T, Schott
M, Spitzweg C, Schmoll HJ.
Oncol Res Treat. 2014;37(6):316-22. doi: 10.1159/000362613. Epub 2014 May 12.
PMID:
24903762
Similar articles
Select item 24816725 43.
Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9)
agonist, in patients with metastatic colorectal carcinoma and disease control after
chemotherapy: a randomised, double-blind, placebo-controlled trial.
Schmoll HJ, Wittig B, Arnold D, Riera-Knorrenschild J, Nitsche D, Kroening H, Mayer F,
Andel J, Ziebermayr R, Scheithauer W.
J Cancer Res Clin Oncol. 2014 Sep;140(9):1615-24. doi: 10.1007/s00432-014-1682-7. Epub
2014 May 10.
PMID:
24816725
Free PMC Article
Similar articles
Select item 24671742 44.
Quality assurance in the treatment of colorectal cancer: the EURECCA initiative.
Breugom AJ, Boelens PG, van den Broek CB, Cervantes A, Van Cutsem E, Schmoll HJ,
Valentini V, van de Velde CJ.
Ann Oncol. 2014 Aug;25(8):1485-92. doi: 10.1093/annonc/mdu039. Epub 2014 Mar 26.
Review.
PMID:
24671742
Similar articles
Select item 24658964 45.
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib
doses than younger patients: a subanalysis of the randomized CML-Study IV.
Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L,
Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M,
Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A,
Hasford J, Hehlmann R, Saußele S; German Chronic Myeloid Leukemia Study Group.;
Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK)..
Ann Hematol. 2014 Jul;93(7):1167-76.
PMID:
24658964
Free PMC Article
Similar articles
Select item 24558023 46.
Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.
Lestuzzi C, Vaccher E, Talamini R, Lleshi A, Meneguzzo N, Viel E, Scalone S, Tartuferi L,
Buonadonna A, Ejiofor L, Schmoll HJ.
Ann Oncol. 2014 May;25(5):1059-64. doi: 10.1093/annonc/mdu055. Epub 2014 Feb 20.
PMID:
24558023
Similar articles
Select item 24548866 47.
Epidemiology and natural history of central venous access device use and infusion pump
function in the NO16966 trial.
Chu E, Haller D, Cartwright T, Twelves C, Cassidy J, Sun W, Saif MW, McKenna E, Lee S,
Schmoll HJ.
Br J Cancer. 2014 Mar 18;110(6):1438-45. doi: 10.1038/bjc.2014.74. Epub 2014 Feb 18.
PMID:
24548866
Free PMC Article
Similar articles
Select item 24445520 48.
Colorectal cancer in 2013: Towards improved drugs, combinations and patient selection.
Schmoll HJ, Stein A.
Nat Rev Clin Oncol. 2014 Feb;11(2):79-80. doi: 10.1038/nrclinonc.2013.254. Epub 2014 Jan
21. Review. No abstract available.
PMID:
24445520
Similar articles
Select item 24330038 49.
Crizotinib in refractory ALK-positive diffuse large B-cell lymphoma: a case report with a
short-term response.
Wass M, Behlendorf T, Schädlich B, Mottok A, Rosenwald A, Schmoll HJ, Jordan K.
Eur J Haematol. 2014 Mar;92(3):268-70. doi: 10.1111/ejh.12240. Epub 2014 Jan 10. No
abstract available.
PMID:
24330038
Similar articles
Select item 24183379 50.
EURECCA colorectal: multidisciplinary management: European consensus conference colon
& rectum.
van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, Beets-
Tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B,
Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-Booth J, Meldolesi E,
Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A,
Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA,
Aristei C, Valentini V.
Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048. Epub 2013 Oct 31.
PMID:
24183379
Similar articles
Select item 24166088 51.
Treatment of adolescents and young adults (AYA) with cancer in a multidisciplinary setting:
on the way to a highly specialized AYA unit.
Bernig T, Jahn F, Witkowsky S, Huehn R, Hentschel A, Kegel T, Schmoll HJ, Körholz D.
Klin Padiatr. 2013 Nov;225(6):335-8. doi: 10.1055/s-0033-1358663. Epub 2013 Oct 28.
PMID:
24166088
Similar articles
Select item 24078656 52.
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up.
Oldenburg J, Fosså SD, Nuver J, Heidenreich A, Schmoll HJ, Bokemeyer C, Horwich A,
Beyer J, Kataja V; ESMO Guidelines Working Group..
Ann Oncol. 2013 Oct;24 Suppl 6:vi125-32. doi: 10.1093/annonc/mdt304. No abstract
available.
PMID:
24078656
Similar articles
Select item 24127333 53.
A global analysis of multitrial data investigating quality of life and symptoms as prognostic
factors for survival in different tumor sites.
Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E,
Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner
H, Schmucker-Von Koch J, Weis J, Bottomley A; Patient Reported Outcomes and Behavioral
Evidence (PROBE) and the European Organization for Research and Treatment of Cancer
(EORTC) Clinical Groups..
Cancer. 2014 Jan 15;120(2):302-11. doi: 10.1002/cncr.28382. Epub 2013 Oct 11.
PMID:
24127333
Free Article
Similar articles
Select item 24024696 54.
Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or
gastro-esophageal cancer: results of a multicenter phase I/II study.
Stein A, Arnold D, Thuss-Patience PC, Moehler M, Grothe W, Seufferlein T, Reinacher-
Schick A, Geissler M, Hofheinz RD, Schmoll HJ.
Acta Oncol. 2014 Mar;53(3):392-8. doi: 10.3109/0284186X.2013.833346. Epub 2013 Sep 12.
PMID:
24024696
Similar articles
Select item 23955142 55.
[S3-guideline colorectal cancer version 1.0].
Pox C, Aretz S, Bischoff SC, Graeven U, Hass M, Heußner P, Hohenberger W, Holstege A,
Hübner J, Kolligs F, Kreis M, Lux P, Ockenga J, Porschen R, Post S, Rahner N, Reinacher-
Schick A, Riemann JF, Sauer R, Sieg A, Scheppach W, Schmitt W, Schmoll HJ, Schulmann
K, Tannapfel A, Schmiegel W; Leitlinienprogramm Onkologie der AWMF.; Deutschen
Krebsgesellschaft e. V.; Deutschen Krebshilfe e. V..
Z Gastroenterol. 2013 Aug;51(8):753-854. doi: 10.1055/s-0033-1350264. Epub 2013 Aug 16.
German. No abstract available.
PMID:
23955142
Free Article
Similar articles
Select item 23864061 56.
Pulmonary embolism in oncologic patients: frequency and embolus burden of symptomatic
and unsuspected events.
Bach AG, Schmoll HJ, Beckel C, Behrmann C, Spielmann RP, Wienke A, Abbas J, Surov A.
Acta Radiol. 2014 Feb;55(1):45-53. doi: 10.1177/0284185113491569. Epub 2013 Jul 17.
PMID:
23864061
Similar articles
Select item 23769991 57.
EURECCA colorectal: multidisciplinary mission statement on better care for patients with
colon and rectal cancer in Europe.
van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, van den
Broek CB, Brown G, Coebergh JW, Cutsem EV, Espin E, Gore-Booth J, Glimelius B,
Haustermans K, Henning G, Iversen LH, Han van Krieken J, Marijnen CA, Mroczkowski P,
Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten HJ, Schmoll
HJ, Smith J, Tanis PJ, Taylor C, Wibe A, Gambacorta MA, Meldolesi E, Wiggers T,
Cervantes A, Valentini V; European Registration of Cancer Care..
Eur J Cancer. 2013 Sep;49(13):2784-90. doi: 10.1016/j.ejca.2013.04.032. Epub 2013 Jun 14.
PMID:
23769991
Similar articles
Select item 23642327 58.
Improving outcomes in colorectal cancer: where do we go from here?
Van Cutsem E, Borràs JM, Castells A, Ciardiello F, Ducreux M, Haq A, Schmoll HJ,
Tabernero J.
Eur J Cancer. 2013 Jul;49(11):2476-85. doi: 10.1016/j.ejca.2013.03.026. Epub 2013 Apr 30.
Review.
PMID:
23642327
Free Article
Similar articles
Select item 23634197 59.
Systemic treatment of liver metastases from colorectal cancer.
Stein A, Schmoll HJ.
Ther Adv Med Oncol. 2013 May;5(3):193-203. doi: 10.1177/1758834012473347.
PMID:
23634197
Free PMC Article
Similar articles
Select item 23463625 60.
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is
effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II
study of the AIO colorectal study group.
Schmiegel W, Reinacher-Schick A, Arnold D, Kubicka S, Freier W, Dietrich G, Geißler M,
Hegewisch-Becker S, Tannapfel A, Pohl M, Hinke A, Schmoll HJ, Graeven U.
Ann Oncol. 2013 Jun;24(6):1580-7. doi: 10.1093/annonc/mdt028. Epub 2013 Mar 4.
PMID:
23463625
Similar articles
61.
German Association of Endocrine Surgeons practice guideline for the surgical management of
malignant thyroid tumors.
Dralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle
B, Scheuba C, Clerici T, Hermann M, Kußmann J, Lorenz K, Nies C, Schabram P, Trupka A,
Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R,
Schober O, Rimmele H, Machens A; German Societies of General and Visceral Surgery;
Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and
the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V..
Langenbecks Arch Surg. 2013 Mar;398(3):347-75. doi: 10.1007/s00423-013-1057-6. Epub
2013 Mar 3. Review.
PMID:
23456424
Similar articles
Select item 23449351 62.
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing
cediranib, bevacizumab and chemotherapy.
Jürgensmeier JM, Schmoll HJ, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D,
Hoff PM.
Br J Cancer. 2013 Apr 2;108(6):1316-23. doi: 10.1038/bjc.2013.79. Epub 2013 Feb 28.
PMID:
23449351
Free PMC Article
Similar articles
Select item 23177514 63.
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an
international, multicentre, randomised, placebo-controlled, phase 3 trial.
Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O,
Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz HJ, Goldberg RM, Sargent DJ,
Cihon F, Cupit L, Wagner A, Laurent D; CORRECT Study Group..
Lancet. 2013 Jan 26;381(9863):303-12. doi: 10.1016/S0140-6736(12)61900-X. Epub 2012
Nov 22.
PMID:
23177514
Similar articles
Select item 23168367 64.
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy
(MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell
lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Schmitz N, Nickelsen M, Ziepert M, Haenel M, Borchmann P, Schmidt C, Viardot A, Bentz
M, Peter N, Ehninger G, Doelken G, Ruebe C, Truemper L, Rosenwald A, Pfreundschuh M,
Loeffler M, Glass B; German High-Grade Lymphoma Study Group (DSHNHL)..
Lancet Oncol. 2012 Dec;13(12):1250-9. doi: 10.1016/S1470-2045(12)70481-3. Epub 2012
Nov 16.
PMID:
23168367
Similar articles
Select item 23168362 65.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer
(AVANT): a phase 3 randomised controlled trial.
de Gramont A, Van Cutsem E, Schmoll HJ, Tabernero J, Clarke S, Moore MJ, Cunningham
D, Cartwright TH, Hecht JR, Rivera F, Im SA, Bodoky G, Salazar R, Maindrault-Goebel F,
Shacham-Shmueli E, Bajetta E, Makrutzki M, Shang A, André T, Hoff PM.
Lancet Oncol. 2012 Dec;13(12):1225-33. doi: 10.1016/S1470-2045(12)70509-0. Epub 2012
Nov 16.
PMID:
23168362
Similar articles
Select item 23062719 66.
Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and
vomiting in a range of tumor types.
Aapro MS, Schmoll HJ, Jahn F, Carides AD, Webb RT.
Cancer Treat Rev. 2013 Feb;39(1):113-7. doi: 10.1016/j.ctrv.2012.09.002. Epub 2012 Oct 11.
Review.
PMID:
23062719
Similar articles
Select item 23012255 67.
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a
personalized approach to clinical decision making.
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger
B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello
F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J,
Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-
Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S,
Cervantes A.
Ann Oncol. 2012 Oct;23(10):2479-516.
PMID:
23012255
Similar articles
Select item 22965961 68.
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for
patients with advanced colorectal cancer: a double-blind, randomized phase III study
(HORIZON III).
Schmoll HJ, Cunningham D, Sobrero A, Karapetis CS, Rougier P, Koski SL, Kocakova I,
Bondarenko I, Bodoky G, Mainwaring P, Salazar R, Barker P, Mookerjee B, Robertson J,
Van Cutsem E.
J Clin Oncol. 2012 Oct 10;30(29):3588-95. doi: 10.1200/JCO.2012.42.5355. Epub 2012 Sep
10.
PMID:
22965961
Similar articles
Select item 22897915 69.
Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer:
presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.
Stein A, Glockzin G, Wienke A, Arnold D, Edelmann T, Hildebrandt B, Hollerbach S,
Illerhaus G, Königsrainer A, Richter M, Schlitt HJ, Schmoll HJ.
BMC Cancer. 2012 Aug 16;12:356. doi: 10.1186/1471-2407-12-356. Review.
PMID:
22897915
Free PMC Article
Similar articles
Select item 22889321 70.
Right flank pain and high fever in a neutropenic patient with acute lymphoblastic leukaemia.
Christopeit M, Lindner A, Surov A, Weber T, Vehreschild MJ, Bialek R, Schmoll HJ.
Mycoses. 2013 Jan;56(1):90-2. doi: 10.1111/j.1439-0507.2012.02231.x. Epub 2012 Aug 13.
No abstract available.
PMID:
22889321
Similar articles
Select item 22846976 71.
Administration of chemotherapy by an arteriovenous fistula in a patient with metastatic rectal
cancer after life-threatening, port thrombosis-associated cava superior syndrome. An option
for patients without possibility of peripheral or central venous access.
Stein A, Hiemer S, Jordan K, Arnold D, Schmoll HJ.
Onkologie. 2012;35(7-8):440-2. doi: 10.1159/000341083. Epub 2012 Jul 12.
PMID:
22846976
Similar articles
Select item 22721496 72.
Cyclosporine area under the curve after allogeneic hematopoietic stem cell transplantation is
an indicator of Epstein-Barr virus DNAemia.
Christopeit M, Janssen N, Weber T, Bacher U, Lautenschläger C, Oehme A, Kekulé AS,
Schmoll HJ.
Leuk Lymphoma. 2013 Jan;54(1):133-7. doi: 10.3109/10428194.2012.705001. Epub 2012
Sep 8.
PMID:
22721496
Similar articles
Select item 22551107 73.
Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger
C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M,
Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A,
Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F,
Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B;
FIRM-ACT Study Group..
N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May
2.
PMID:
22551107
Free Article
Similar articles
Select item 22464311 74.
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the
literature.
Calabrò F, Albers P, Bokemeyer C, Martin C, Einhorn LH, Horwich A, Krege S, Schmoll HJ,
Sternberg CN, Daugaard G.
Eur Urol. 2012 Jun;61(6):1212-21. doi: 10.1016/j.eururo.2012.03.038. Epub 2012 Mar 24.
Review.
PMID:
22464311
Similar articles
Select item 22156443 75.
Perspectives for onkologie.
Schmoll HJ, Hallek M.
Onkologie. 2011;34(12):659. doi: 10.1159/000335096. Epub 2011 Nov 25. No abstract
available.
PMID:
22156443
Free Article
Similar articles
Select item 22085384 76.
Adjuvant therapy for early colon cancer: current status.
Stein A, Hiemer S, Schmoll HJ.
Drugs. 2011 Dec 3;71(17):2257-75. doi: 10.2165/11594490-000000000-00000. Review.
PMID:
22085384
Similar articles
Select item 22009076 77.
Has the new TNM classification for colorectal cancer improved care?
Nagtegaal ID, Quirke P, Schmoll HJ.
Nat Rev Clin Oncol. 2011 Oct 18;9(2):119-23. doi: 10.1038/nrclinonc.2011.157. Review.
PMID:
22009076
Similar articles
Select item 21986225 78.
Advanced seminoma and nonseminoma: SIU/ICUD Consensus Meeting on Germ Cell
Tumors (GCT), Shanghai 2009.
Schmoll HJ, Osanto S, Kawai K, Einhorn L, Fizazi K.
Urology. 2011 Oct;78(4 Suppl):S456-68. doi: 10.1016/j.urology.2011.08.001.
PMID:
21986225
Similar articles
Select item 21985846 79.
Current treatment of stage I testicular seminoma.
Schmoll HJ, Heissner K.
Onkologie. 2011;34(10):495-6. doi: 10.1159/000332955. Epub 2011 Sep 23. No abstract
available.
PMID:
21985846
Similar articles
Select item 21958103 80.
Examining the relationships among health-related quality-of-life indicators in cancer patients
participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H,
Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q,
Taphoorn MJ, Weis J, Bottomley A; European Organisation for Research and Treatment of
Cancer Clinical Groups..
Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):587-99. doi: 10.1586/erp.11.51.
PMID:
21958103
Similar articles
[Unexplained fever and B-symptoms in a young male Black African].
Weber T, Ettrich T, Christopeit M, Lindner A, Holzhausen HJ, Oehme A, Arnold D, Wolf
HH, Lübbert C, Kekulé AS, Schmoll HJ, Werdan K, Ebelt H.
Internist (Berl). 2012 Jan;53(1):93-8. doi: 10.1007/s00108-011-2912-6. German.
PMID:
21953027
Similar articles
Select item 21821551 82.
Role of the multidisciplinary team in breast cancer management: results from a large
international survey involving 39 countries.
Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne
C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, Piccart-Gebhart MJ, de Azambuja
E.
Ann Oncol. 2012 Apr;23(4):853-9. doi: 10.1093/annonc/mdr352. Epub 2011 Aug 4.
PMID:
21821551
Similar articles
Select item 21684072 83.
Sequelae of treatment in long-term survivors of testis cancer.
Abouassaly R, Fossa SD, Giwercman A, Kollmannsberger C, Motzer RJ, Schmoll HJ,
Sternberg CN.
Eur Urol. 2011 Sep;60(3):516-26. doi: 10.1016/j.eururo.2011.05.055. Epub 2011 Jun 12.
Review.
PMID:
21684072
Similar articles
Select item 21633049 84.
The diagnosis and management of gastric cancer: expert discussion and recommendations
from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E,
Ducreux M, Glynne-Jones R, Grothey A, Haller D, Haustermans K, Kerr D, Nordlinger B,
Marshall J, Minsky BD, Kang YK, Labianca R, Lordick F, Ohtsu A, Pavlidis N, Roth A,
Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Van de Velde C, Zalcberg J.
Ann Oncol. 2011 Jun;22 Suppl 5:v1-9. doi: 10.1093/annonc/mdr284.
PMID:
21633049
Similar articles
Select item 21606410 85.
Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with
intravenous chemotherapy and intraperitoneal catumaxomab.
Rüssel J, Stein A, Behrmann C, Hauptmann S, Krummenerl P, Schmoll HJ, Arnold D.
J Clin Oncol. 2011 Aug 1;29(22):e644-6. doi: 10.1200/JCO.2010.34.3939. Epub 2011 May
23. No abstract available.
PMID:
21606410
Similar articles
Select item 21601694 86.
Do we need oncology trials tailored for the elderly or frail?
Schmoll HJ.
Lancet. 2011 May 21;377(9779):1725-7. doi: 10.1016/S0140-6736(11)60654-5. No abstract
available.
PMID:
21601694
Similar articles
Select item 21577036 87.
[Gastrointestinal tumors--interdisciplinary discussion over new data].
Arnold D, Fietkau R, Hegewisch-Becker S, Höhler T, Knoefel WT, Kubicka S, Lang H,
Liersch T, Luster M, Oettle H, Reinacher-Schick A, Ridwelski K, Riess H, Rödel C, Rüschoff
J, Schmiegel W, Schmoll HJ, Vanhoefer U.
Onkologie. 2011;34 Suppl 3:1-31. doi: 10.1159/000328047. Epub 2011 Apr 27. German. No
abstract available.
PMID:
21577036
Free Article
Similar articles
Select item 21547891 88.
Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal
stromal cells from allogeneic related donors: report of five cases.
Keyszer G, Christopeit M, Fick S, Schendel M, Taute BM, Behre G, Müller LP, Schmoll HJ.
Arthritis Rheum. 2011 Aug;63(8):2540-2. doi: 10.1002/art.30431. No abstract available.
PMID:
21547891
Free Article
Similar articles
Select item 21476183 89.
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].
Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P,
Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W,
Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J,
Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M,
Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B,
Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner
J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J,
Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg
R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S,
Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp
W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G,
Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T,
Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K,
Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H,
Wittekind C; AWMF.; AWMF..
Z Gastroenterol. 2011 Apr;49(4):461-531. doi: 10.1055/s-0031-1273201. Epub 2011 Apr 7.
German. No abstract available.
PMID:
21476183
Similar articles
Select item 21393030 90.
Metastases to the breast from non-mammary malignancies: primary tumors, prevalence,
clinical signs, and radiological features.
Surov A, Fiedler E, Holzhausen HJ, Ruschke K, Schmoll HJ, Spielmann RP.
Acad Radiol. 2011 May;18(5):565-74. doi: 10.1016/j.acra.2010.12.009. Epub 2011 Mar 9.
PMID:
21393030
Similar articles
Select item 21383294 91.
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy
for stage III colon cancer.
Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Gilberg F,
Rittweger K, Schmoll HJ.
J Clin Oncol. 2011 Apr 10;29(11):1465-71. doi: 10.1200/JCO.2010.33.6297. Epub 2011 Mar
7.
PMID:
21383294
Similar articles
Select item 21199884 92.
Pancreatic cancer treatment and research: an international expert panel discussion.
Tempero MA, Berlin J, Ducreux M, Haller D, Harper P, Khayat D, Schmoll HJ, Sobrero A,
Van Cutsem E.
Ann Oncol. 2011 Jul;22(7):1500-6. doi: 10.1093/annonc/mdq545. Epub 2011 Jan 3. Review.
PMID:
21199884
Similar articles
Select item 21154162 93.
Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational
research in clinical trials.
Zwierzina H, Bardelli A, Ciardiello F, Gariboldi M, Håkansson L, Lambrechts D, Lind GE,
Loeffler-Ragg J, Schmoll H, Siena S, Tabernero J, Van Cutsem E.
Curr Opin Mol Ther. 2010 Dec;12(6):703-11. Review.
PMID:
21154162
Similar articles
Select item 21059637 94.
A randomized phase III study comparing standard dose BEP with sequential high-dose
cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis
germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC
30974).
Daugaard G, Skoneczna I, Aass N, De Wit R, De Santis M, Dumez H, Marreaud S, Collette
L, Lluch JR, Bokemeyer C, Schmoll HJ.
Ann Oncol. 2011 May;22(5):1054-61. doi: 10.1093/annonc/mdq575. Epub 2010 Nov 8.
PMID:
21059637
Free PMC Article
Similar articles
Select item 20838387 95.
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan
and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a
triple antiemetic combination.
Jordan K, Jahn F, Jahn P, Behlendorf T, Stein A, Ruessel J, Kegel T, Schmoll HJ.
Bone Marrow Transplant. 2011 Jun;46(6):784-9. doi: 10.1038/bmt.2010.205. Epub 2010 Sep
13.
PMID:
20838387
Similar articles
Select item 20816370 96.
S-1 for advanced colorectal cancer: do we need another oral fluorouracil prodrug?
Schmoll HJ.
Lancet Oncol. 2010 Sep;11(9):808-9. doi: 10.1016/S1470-2045(10)70201-1. No abstract
available.
PMID:
20816370
Similar articles
Select item 20555066 97.
Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and
follow-up.
Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V; ESMO
Guidelines Working Group..
Ann Oncol. 2010 May;21 Suppl 5:v147-54. doi: 10.1093/annonc/mdq177. No abstract
available.
PMID:
20555066
Similar articles
Select item 20555065 98.
Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-
up.
Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V; ESMO
Guidelines Working Group..
Ann Oncol. 2010 May;21 Suppl 5:v140-6. doi: 10.1093/annonc/mdq176. No abstract
available.
PMID:
20555065
Similar articles
Select item 20534623 99.
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert
opinion and recommendations derived from the 11th ESMO/World Congress on
Gastrointestinal Cancer, Barcelona, 2009.
Van Cutsem E, Dicato M, Arber N, Berlin J, Cervantes A, Ciardiello F, De Gramont A, Diaz-
Rubio E, Ducreux M, Geva R, Glimelius B, Glynne Jones R, Grothey A, Gruenberger T,
Haller D, Haustermans K, Labianca R, Lenz HJ, Minsky B, Nordlinger B, Ohtsu A, Pavlidis
N, Rougier P, Schmiegel W, Van de Velde C, Schmoll HJ, Sobrero A, Tabernero J.
Ann Oncol. 2010 Jun;21 Suppl 6:vi1-10. doi: 10.1093/annonc/mdq273.
PMID:
20534623
Similar articles
Select item 20532795 100.
Histological evidence for the existence of germ cell tumor cells showing embryonal
carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity.
Mueller T, Mueller LP, Holzhausen HJ, Witthuhn R, Albers P, Schmoll HJ.
Histochem Cell Biol. 2010 Aug;134(2):197-204. doi: 10.1007/s00418-010-0710-1. Epub
2010 Jun 8.
PMID:
20532795
Similar articles
101.
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and
survival in acute myeloid leukemia.
Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-
Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U,
Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE,
Dugas M, Serve H; Study Alliance Leukemia..
Blood. 2010 Nov 4;116(18):3564-71. doi: 10.1182/blood-2009-09-240978. Epub 2010 May
24.
PMID:
20498303
Free PMC Article
Similar articles
Select item 20431307 102.
[Specific treatment situations in metastatic colorectal cancer].
Arnold D, Schmoll HJ, Lang H, Knoefel WT, Ridwelski K, Trarbach T, Staib L, Kirchner T,
Geissler M, Seufferlein T, Amthauer H, Riess H, Schlitt HJ, Piso P.
Onkologie. 2010;33 Suppl 4:8-18. doi: 10.1159/000308447. Epub 2010 Apr 23. Review.
German.
PMID:
20431307
Similar articles
Select item 20431306 103.
[Adjuvant therapy in colon cancer].
Reinacher-Schick A, Arnold D, Trarbach T, Ridwelski K, Bruch HP, Kirchner T, Kubicka S,
Schmoll HJ.
Onkologie. 2010;33 Suppl 4:2-7. doi: 10.1159/000308436. Epub 2010 Apr 23. Review.
German.
PMID:
20431306
Similar articles
Select item 21789132 104.
Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line
treatment of gastrointestinal cancer.
Peinert S, Grothe W, Stein A, Müller LP, Ruessel J, Voigt W, Schmoll HJ, Arnold D.
Ther Adv Med Oncol. 2010 May;2(3):161-74. doi: 10.1177/1758834010365061.
PMID:
21789132
Free PMC Article
Similar articles
Select item 20228848 105.
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a
feasibility study.
Jordan K, Wolf HH, Voigt W, Kegel T, Mueller LP, Behlendorf T, Sippel C, Arnold D,
Schmoll HJ.
Bone Marrow Transplant. 2010 Dec;45(12):1704-9. doi: 10.1038/bmt.2010.50. Epub 2010
Mar 15.
PMID:
20228848
Similar articles
Select item 20072998 106.
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on
February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).
Schmiegel W, Pox C, Reinacher-Schick A, Adler G, Arnold D, Fleig W, Fölsch UR,
Frühmorgen P, Graeven U, Heinemann V, Hohenberger W, Holstege A, Junginger T, Kopp I,
Kühlbacher T, Porschen R, Propping P, Riemann JF, Rödel C, Sauer R, Sauerbruch T,
Schmitt W, Schmoll HJ, Seufferlein T, Zeitz M, Selbmann HK; Federal Committee of
Physicians and Health Insurers..
Z Gastroenterol. 2010 Jan;48(1):65-136. doi: 10.1055/s-0028-1109936. Epub 2010 Jan 13. No
abstract available.
PMID:
20072998
Similar articles
Select item 20062582 107.
Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of
metastases.
Schmiegel W, Pox C, Arnold D, Porschen R, Rödel C, Reinacher-Schick A; Association of
the Scientific Medical Societies in Germany.; German Cancer Aid.; German Cancer Society.;
German Society for Digestive and Metabolic Diseases.; German Society for General and
Visceral Surgery.; German Society for Hematology and Oncology.; German Society for
Pathology.; German Society for Radiooncology.; German Roentgen Society.; German Joint
Society for Clinical Chemistry and Laboratory Medicine.; German Society for
Coloproctology.; Association of Stoma Patients and Persons with Intestinal Cancer.; German
Crohn's Disease and Ulcerative Colitis Association.; German Society for Internal Medicine..
Dtsch Arztebl Int. 2009 Dec;106(51-52):843-8. doi: 10.3238/arztebl.2009.0843. Epub 2009
Dec 18. Erratum in: Dtsch Arztebl Int. 2010 Feb;107(5):74.
PMID:
20062582
Free PMC Article
Similar articles
Select item 20009905 108.
Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in
platinum- and paclitaxel-pretreated epithelial ovarian cancer.
Seliger G, Mueller LP, Kegel T, Kantelhardt EJ, Grothey A, Groe R, Strauss HG, Koelbl H,
Thomssen C, Schmoll HJ.
Int J Gynecol Cancer. 2009 Nov;19(8):1446-53. doi: 10.1111/IGC.0b013e3181b62f38.
PMID:
20009905
Similar articles
Select item 19945239 109.
Rectal cancer and synchronous metastases: resection of primary tumor or not?
Trarbach T, Schmoll HJ.
Gastroenterol Clin Biol. 2009 Dec;33(12):1098-100. doi: 10.1016/j.gcb.2009.10.011. No
abstract available.
PMID:
19945239
Free Article
Similar articles
Select item 19775661 110.
Current treatment of high risk testis cancer.
Schmoll HJ, Jordan K.
Eur J Cancer. 2009 Sep;45 Suppl 1:433-5. doi: 10.1016/S0959-8049(09)70079-6. No abstract
available.
PMID:
19775661
Similar articles
Select item 19773753 111.
Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with
refractory solid tumours: results of a phase I trial.
Arnold D, Voigt W, Kiewe P, Behrmann C, Lindemann S, Reif S, Wiesinger H, Giurescu M,
Thiel E, Schmoll HJ.
Br J Cancer. 2009 Oct 20;101(8):1241-7. doi: 10.1038/sj.bjc.6605327. Epub 2009 Sep 22.
PMID:
19773753
Free PMC Article
Similar articles
Select item 19735058 112.
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid
carcinoma of the follicular epithelium.
Matuszczyk A, Petersenn S, Voigt W, Kegel T, Dralle H, Schmoll HJ, Bockisch A, Mann K.
Horm Metab Res. 2010 Jan;42(1):61-4. doi: 10.1055/s-0029-1238294. Epub 2009 Sep 4.
PMID:
19735058
Similar articles
Select item 19725867 113.
Impact of quality of life parameters and coping strategies on postchemotherapy nausea and
vomiting.
Jordan K, Grothey A, Pelz T, Lautenschläger C, Franke U, Schöber C, Schmoll HJ.
Eur J Cancer Care (Engl). 2010 Sep;19(5):603-9. doi: 10.1111/j.1365-2354.2009.01099.x.
Epub 2009 Aug 31.
PMID:
19725867
Similar articles
Select item 19629539 114.
Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured
nursing intervention: a cluster-randomized multicenter trial.
Jahn P, Renz P, Stukenkemper J, Book K, Kuss O, Jordan K, Horn I, Thoke-Colberg A,
Schmoll HJ, Landenberger M.
Support Care Cancer. 2009 Dec;17(12):1543-52. doi: 10.1007/s00520-009-0698-z. Epub
2009 Jul 23.
PMID:
19629539
Similar articles
Select item 19595467 115.
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus
Conference (EURECA-CC2).
Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, Haustermans K,
Maingon P, Overgaard J, Pahlman L, Quirke P, Schmoll HJ, Sebag-Montefiore D, Taylor I,
Van Cutsem E, Van de Velde C, Cellini N, Latini P; Scientific Committee..
Radiother Oncol. 2009 Aug;92(2):148-63. doi: 10.1016/j.radonc.2009.06.027.
PMID:
19595467
Similar articles
Select item 19454475 116.
Testicular non-seminoma: ESMO clinical recommendations for diagnosis, treatment and
follow-up.
Schmoll HJ, Jordan K, Huddart R, Laguna MP, Horwich A, Fizazi K, Kataja V; ESMO
Guidelines Working Group..
Ann Oncol. 2009 May;20 Suppl 4:89-96. doi: 10.1093/annonc/mdp139. Review. No abstract
available.
PMID:
19454475
Similar articles
Select item 19454474 117.
Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-
up.
Schmoll HJ, Jordan K, Huddart R, Laguna MP, Horwich A, Fizazi K, Kataja V; ESMO
Guidelines Working Group..
Ann Oncol. 2009 May;20 Suppl 4:83-8. doi: 10.1093/annonc/mdp138. Review. No abstract
available.
PMID:
19454474
Similar articles
Select item 19568773 118.
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a
broad range of moderately emetogenic chemotherapies and tumor types: a randomized,
double-blind study.
Rapoport BL, Jordan K, Boice JA, Taylor A, Brown C, Hardwick JS, Carides A, Webb T,
Schmoll HJ.
Support Care Cancer. 2010 Apr;18(4):423-31. doi: 10.1007/s00520-009-0680-9. Epub 2009
Jul 1.
PMID:
19568773
Similar articles
Select item 19546594 119.
[Gastrointestinal tumors. Foreward].
Schmoll HJ, Schmiegel W.
Onkologie. 2009;32 Suppl 2:1. doi: 10.1159/000213481. Epub 2009 Jun 22. German. No
abstract available.
PMID:
19546594
Free Article
Similar articles
Select item 19536310 120.
Anthracycline extravasation injuries: management with dexrazoxane.
Jordan K, Behlendorf T, Mueller F, Schmoll HJ.
Ther Clin Risk Manag. 2009 Apr;5(2):361-6. Epub 2009 May 20.
PMID:
19536310
Free PMC Article
Similar articles
121.
The management of hepatocellular carcinoma. Current expert opinion and recommendations
derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D, De Gramont A,
Diaz-Rubio E, Ducreux M, Gruenberger T, Haller D, Haustermans K, Hoff P, Kerr D,
Labianca R, Moore M, Nordlinger B, Ohtsu A, Rougier P, Scheithauer W, Schmoll HJ,
Sobrero A, Tabernero J, van de Velde C.
Ann Oncol. 2009 Jun;20 Suppl 7:vii1-vii6. doi: 10.1093/annonc/mdp281.
PMID:
19497945
Similar articles
Select item 19508388 122.
Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human
mesenchymal stem cells requires their substantial intratumoral presence.
Luetzkendorf J, Mueller LP, Mueller T, Caysa H, Nerger K, Schmoll HJ.
J Cell Mol Med. 2010 Sep;14(9):2292-304. doi: 10.1111/j.1582-4934.2009.00794.x.
PMID:
19508388
Free PMC Article
Similar articles
Select item 19484194 123.
[New antiemetic strategies - not only in oncology].
Jordan K, Müller F, Schmoll HJ.
Internist (Berl). 2009 Jul;50(7):887-94. doi: 10.1007/s00108-009-2411-1. Review. German.
PMID:
19484194
Similar articles
Select item 19384552 124.
[Therapeutic application of mesenchymal stromal cells in autoimmune disease: rationale and
initial clinical experience].
Keysser G, Müller L, Schendel M, Schmoll HJ.
Z Rheumatol. 2009 May;68(3):220, 222-7. doi: 10.1007/s00393-008-0394-2. Review.
German.
PMID:
19384552
Similar articles
Select item 19352469 125.
Accomplishments in 2007 in the management of advanced gastroesophageal cancer.
Ajani JA, Schmoll HJ.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S47-50.
PMID:
19352469
Free PMC Article
Similar articles
Select item 19273695 126.
When wishful thinking leads to a misty-eyed appraisal: the story of the adjuvant colon cancer
trials with edrecolomab.
Schmoll HJ, Arnold D.
J Clin Oncol. 2009 Apr 20;27(12):1926-9. doi: 10.1200/JCO.2008.20.6284. Epub 2009 Mar
9. No abstract available.
PMID:
19273695
Similar articles
Select item 19221495 127.
The role of promoter CpG methylation in the epigenetic control of stem cell related genes
during differentiation.
Dansranjavin T, Krehl S, Mueller T, Mueller LP, Schmoll HJ, Dammann RH.
Cell Cycle. 2009 Mar 15;8(6):916-24. Epub 2009 Mar 26.
PMID:
19221495
Similar articles
Select item 19203899 128.
Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment
of patients with metastatic colorectal cancer: HORIZON III.
Robertson JD, Botwood NA, Rothenberg ML, Schmoll HJ.
Clin Colorectal Cancer. 2009 Jan;8(1):59-60. doi: 10.3816/CCC.2009.n.010.
PMID:
19203899
Similar articles
Select item 19135359 129.
Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in
highly and moderately emetogenic multiple-day chemotherapy.
Jordan K, Kinitz I, Voigt W, Behlendorf T, Wolf HH, Schmoll HJ.
Eur J Cancer. 2009 May;45(7):1184-7. doi: 10.1016/j.ejca.2008.11.046. Epub 2009 Jan 8.
PMID:
19135359
Similar articles
Select item 19033697 130.
[Colorectal carcinoma--primary treatment in case of advanced metastization].
Arnold D, Siewczynski R, Kubicka S, Hacker U, Schmoll HJ.
Onkologie. 2008;31 Suppl 5:3-8. doi: 10.1159/000163066. Epub 2008 Nov 21. Review.
German. Erratum in: Onkologie. 2009 Jun;32(6):336.
PMID:
19033697
Similar articles
Select item 19033695 131.
[Gastrointestinal tumors. Foreword].
Schmoll HJ, Schmiegel W.
Onkologie. 2008;31 Suppl 5:V. doi: 10.1159/000163060. German. No abstract available.
PMID:
19033695
Similar articles
Select item 19023518 132.
Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple
entities and in human mesenchymal stem cells.
Mueller T, Luetzkendorf J, Nerger K, Schmoll HJ, Mueller LP.
Cell Mol Life Sci. 2009 Feb;66(3):495-503. doi: 10.1007/s00018-008-8623-z.
PMID:
19023518
Similar articles
Select item 19018087 133.
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with
metastatic colorectal cancer: a pooled analysis of randomized trials.
Arkenau HT, Arnold D, Cassidy J, Diaz-Rubio E, Douillard JY, Hochster H, Martoni A,
Grothey A, Hinke A, Schmiegel W, Schmoll HJ, Porschen R.
J Clin Oncol. 2008 Dec 20;26(36):5910-7. doi: 10.1200/JCO.2008.16.7759. Epub 2008 Nov
17. Erratum in: J Clin Oncol. 2009 Dec 1;27(34):5859.
PMID:
19018087
Similar articles
Select item 18759205 134.
[Update S3-guideline "colorectal cancer" 2008].
Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R,
Riemann J, Rödel C, Sauer R, Wieser M, Schmitt W, Schmoll HJ, Seufferlein T, Kopp I, Pox
C.
Z Gastroenterol. 2008 Aug;46(8):799-840. doi: 10.1055/s-2008-1027726. Review. German.
No abstract available.
PMID:
18759205
Similar articles
Select item 18751976 135.
"Tumor immunology meets oncology IV", 23rd and 24th May 2008 Martin Luther University
Halle-Wittenberg, Halle, Germany.
Bukur J, Loeffler D, Massa C, Mueller L, Riemann D, Schmoll HJ, Seliger B.
Cancer Immunol Immunother. 2010 Jun;59(6):955-62. doi: 10.1007/s00262-008-0580-8.
Epub 2008 Aug 28. No abstract available.
PMID:
18751976
Similar articles
Select item 18698754 136.
2-(4-(Tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II): a
novel platinum compound that overcomes cisplatin resistance and induces apoptosis by
mechanisms different from that of cisplatin.
Dietrich A, Mueller T, Paschke R, Kalinowski B, Behlendorf T, Reipsch F, Fruehauf A,
Schmoll HJ, Kloft C, Voigt W.
J Med Chem. 2008 Sep 11;51(17):5413-22. doi: 10.1021/jm800334z. Epub 2008 Aug 13.
PMID:
18698754
Similar articles
Select item 18539618 137.
The diagnosis and management of rectal cancer: expert discussion and recommendations
derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007.
Van Cutsem E, Dicato M, Haustermans K, Arber N, Bosset JF, Cunningham D, De Gramont
A, Diaz-Rubio E, Ducreux M, Goldberg R, Glynne-Jones R, Haller D, Kang YK, Kerr D,
Labianca R, Minsky BD, Moore M, Nordlinger B, Rougier P, Scheithauer W, Schmoll HJ,
Sobrero A, Tabernero J, Tempero M, Van de Velde C, Zalcberg J.
Ann Oncol. 2008 Jun;19 Suppl 6:vi1-8. doi: 10.1093/annonc/mdn358.
PMID:
18539618
Similar articles
Select item 18534701 138.
Evidence and research in rectal cancer.
Valentini V, Beets-Tan R, Borras JM, Krivokapić Z, Leer JW, Påhlman L, Rödel C, Schmoll
HJ, Scott N, Velde CV, Verfaillie C.
Radiother Oncol. 2008 Jun;87(3):449-74. doi: 10.1016/j.radonc.2008.05.022. Epub 2008 Jun
3. Review.
PMID:
18534701
Similar articles
Select item 18445855 139.
Re: Should capecitabine replace infusional fluorouracil and leucovorin when combined with
oxaliplatin in metastatic colorectal cancer?
Cassidy J, Schmoll HJ, Van Cutsem E.
J Clin Oncol. 2008 May 1;26(13):2226-7; author reply 2228. doi: 10.1200/JCO.2008.16.4244.
No abstract available.
PMID:
18445855
Similar articles
Select item 18445840 140.
Potential regional differences for the tolerability profiles of fluoropyrimidines.
Haller DG, Cassidy J, Clarke SJ, Cunningham D, Van Cutsem E, Hoff PM, Rothenberg ML,
Saltz LB, Schmoll HJ, Allegra C, Bertino JR, Douillard JY, Gustavsson BG, Milano G,
O'Connell M, Rustum Y, Tabernero J, Gilberg F, Sirzén F, Twelves C.
J Clin Oncol. 2008 May 1;26(13):2118-23. doi: 10.1200/JCO.2007.15.2090.
PMID:
18445840
Similar articles
141.
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX)
in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI
Group.
Arnold D, Höhler T, Dittrich C, Lordick F, Seufferlein T, Riemann J, Wöll E, Herrmann T,
Zubel A, Schmoll HJ.
Ann Oncol. 2008 Aug;19(8):1442-9. doi: 10.1093/annonc/mdn150. Epub 2008 Apr 25.
PMID:
18441330
Similar articles
Select item 18380894 142.
Severe thrombocytosis and anemia associated with celiac disease in a young female patient: a
case report.
Voigt W, Jordan K, Sippel C, Amoury M, Schmoll HJ, Wolf HH.
J Med Case Rep. 2008 Apr 1;2:96. doi: 10.1186/1752-1947-2-96.
PMID:
18380894
Free PMC Article
Similar articles
Select item 18279579 143.
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients
with metastatic colorectal cancer.
Arkenau HT, Graeven U, Kubicka S, Grothey A, Englisch-Fritz C, Kretzschmar A, Greil R,
Freier W, Seufferlein T, Hinke A, Schmoll HJ, Schmiegel W, Porschen R; AIO Colorectal
Study Group..
Clin Colorectal Cancer. 2008 Jan;7(1):60-4.
PMID:
18279579
Similar articles
Select item 18191324 144.
European consensus conference on diagnosis and treatment of germ cell cancer: a report of
the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I,
Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S,
Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP,
Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi
L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl
W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S,
Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD,
Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Ares LP,
Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J,
Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE,
Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood
L, von der Maase H.
Eur Urol. 2008 Mar;53(3):478-96. doi: 10.1016/j.eururo.2007.12.024. Epub 2007 Dec 26.
Review.
PMID:
18191324
Similar articles
Select item 18191015 145.
European consensus conference on diagnosis and treatment of germ cell cancer: a report of
the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.
Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I,
Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S,
Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP,
Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi
L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl
W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S,
Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD,
Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Paz-Ares L,
Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J,
Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE,
Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood
L, von der Maase H.
Eur Urol. 2008 Mar;53(3):497-513. doi: 10.1016/j.eururo.2007.12.025. Epub 2007 Dec 26.
PMID:
18191015
Similar articles
Select item 18042838 146.
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable
nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study.
Fizazi K, Oldenburg J, Dunant A, Chen I, Salvioni R, Hartmann JT, De Santis M, Daugaard
G, Flechon A, de Giorgi U, Tjulandin S, Schmoll HJ, Bouzy J, Fossa SD, Fromont G.
Ann Oncol. 2008 Feb;19(2):259-64. Epub 2007 Nov 27.
PMID:
18042838
Similar articles
Select item 17600091 147.
The management of pancreatic cancer. Current expert opinion and recommendations derived
from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006.
Verslype C, Van Cutsem E, Dicato M, Cascinu S, Cunningham D, Diaz-Rubio E, Glimelius
B, Haller D, Haustermans K, Heinemann V, Hoff P, Johnston PG, Kerr D, Labianca R,
Louvet C, Minsky B, Moore M, Nordlinger B, Pedrazzoli S, Roth A, Rothenberg M, Rougier
P, Schmoll HJ, Tabernero J, Tempero M, van de Velde C, Van Laethem JL, Zalcberg J.
Ann Oncol. 2007 Jun;18 Suppl 7:vii1-vii10.
PMID:
17600091
Similar articles
Select item 17914084 148.
Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past,
present, and future recommendations.
Jordan K, Sippel C, Schmoll HJ.
Oncologist. 2007 Sep;12(9):1143-50. Review.
PMID:
17914084
Free Article
Similar articles
Select item 17630019 149.
Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?
Schmoll HJ, Sargent D.
Lancet. 2007 Jul 14;370(9582):105-7. No abstract available. Erratum in: Lancet. 2008 Dec
22;370(9605):2102.
PMID:
17630019
Similar articles
Select item 17596575 150.
Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer
and proposed definitions for future trials.
Punt CJ, Buyse M, Köhne CH, Hohenberger P, Labianca R, Schmoll HJ, Påhlman L, Sobrero
A, Douillard JY.
J Natl Cancer Inst. 2007 Jul 4;99(13):998-1003. Epub 2007 Jun 27. Review.
PMID:
17596575
Similar articles
Select item 17585415 151.
Human chorionic gonadotropin-induced hyperthyroidism in germ cell cancer--a case
presentation and review of the literature.
Voigt W, Maher G, Wolf HH, Schmoll HJ.
Onkologie. 2007 Jun;30(6):330-4. Review.
PMID:
17585415
Similar articles
Select item 17548840 152.
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin
plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study
Group.
Porschen R, Arkenau HT, Kubicka S, Greil R, Seufferlein T, Freier W, Kretzschmar A,
Graeven U, Grothey A, Hinke A, Schmiegel W, Schmoll HJ; AIO Colorectal Study Group..
J Clin Oncol. 2007 Sep 20;25(27):4217-23. Epub 2007 Jun 4.
PMID:
17548840
Similar articles
Select item 17234784 153.
Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth
factor receptor inhibitor-induced cell death in squamous cell cancer.
Lorch JH, Thomas TO, Schmoll HJ.
Cancer Res. 2007 Jan 15;67(2):727-34.
PMID:
17234784
Free Article
Similar articles
Select item 17208005 154.
Comparative activity of antiemetic drugs.
Jordan K, Schmoll HJ, Aapro MS.
Crit Rev Oncol Hematol. 2007 Feb;61(2):162-75. Review.
PMID:
17208005
Similar articles
Select item 17205281 155.
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute
chemotherapy-induced emesis.
Jordan K, Hinke A, Grothey A, Voigt W, Arnold D, Wolf HH, Schmoll HJ.
Support Care Cancer. 2007 Sep;15(9):1023-33. Epub 2007 Jan 5.
PMID:
17205281
Similar articles
Select item 17194911 156.
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a
planned safety analysis in 1,864 patients.
Schmoll HJ, Cartwright T, Tabernero J, Nowacki MP, Figer A, Maroun J, Price T, Lim R,
Van Cutsem E, Park YS, McKendrick J, Topham C, Soler-Gonzalez G, de Braud F, Hill M,
Sirzén F, Haller DG.
J Clin Oncol. 2007 Jan 1;25(1):102-9.
PMID:
17194911
Similar articles
Select item 17030642 157.
Update on capecitabine in colorectal cancer.
Schmoll HJ, Arnold D.
Oncologist. 2006 Oct;11(9):1003-9. Review.
PMID:
17030642
Free Article
Similar articles
Select item 17018712 158.
The integration of targeted agents into systemic therapy of metastatic colorectal cancer.
Arnold D, Siewczynski R, Schmoll HJ.
Ann Oncol. 2006 Sep;17 Suppl 10:x122-8. Review. No abstract available.
PMID:
17018712
Similar articles
Select item 16931776 159.
Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy:
evidence of resistance to apoptosis induction.
Mueller LP, Luetzkendorf J, Mueller T, Reichelt K, Simon H, Schmoll HJ.
Stem Cells. 2006 Dec;24(12):2753-65. Epub 2006 Aug 24.
PMID:
16931776
Free Article
Similar articles
Select item 16915549 160.
[Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
Jordan K, Voigt W, Schmoll HJ.
Dtsch Med Wochenschr. 2006 Aug 25;131(34-35):1869-72. Review. German.
PMID:
16915549
Similar articles
161.
Gastrointestinal tumors.
Schmoll HJ, Arnalod D.
Forum (Genova). 2006;14(1):E3. No abstract available.
PMID:
16873086
Similar articles
Select item 16809641 162.
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert
opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona,
2005.
Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E, Glimelius B,
Goldberg R, Haller D, Haustermans K, Koo-Kang Y, Labianca R, Lang I, Minsky B,
Nordlinger B, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Szawlowski A, van de
Velde C.
Ann Oncol. 2006 Jun;17 Suppl 6:vi13-8. No abstract available.
PMID:
16809641
Similar articles
Select item 16794239 163.
Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in
gastrointestinal cancer treatment: a review.
Arnold D, Peinert S, Voigt W, Schmoll HJ.
Oncologist. 2006 Jun;11(6):602-11. Review.
PMID:
16794239
Free Article
Similar articles
Select item 16583567 164.
[Overview of development status and clinical action. Cisplatin and its analogues].
Voigt W, Dietrich A, Schmoll HJ.
Pharm Unserer Zeit. 2006;35(2):134-43. Review. German. No abstract available.
PMID:
16583567
Similar articles
Select item 16557044 165.
Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of
cisplatin resistance.
Mueller T, Mueller LP, Luetzkendorf J, Voigt W, Simon H, Schmoll HJ.
Tumour Biol. 2006;27(2):71-83. Epub 2006 Mar 24.
PMID:
16557044
Similar articles
Select item 16524979 166.
Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with
dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment.
Schmoll HJ, Aapro MS, Poli-Bigelli S, Kim HK, Park K, Jordan K, von Pawel J, Giezek H,
Ahmed T, Chan CY.
Ann Oncol. 2006 Jun;17(6):1000-6. Epub 2006 Mar 8.
PMID:
16524979
Similar articles
Select item 16518928 167.
[Supportive medicine is also a responsibility of the general practitioner. How you can mitigate
the fear of cancer therapy (interview by Jochen Aumiller)].
Schmoll HJ.
MMW Fortschr Med. 2006 Feb 2;148(5):10. German. No abstract available.
PMID:
16518928
Similar articles
Select item 16356302 168.
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced
colorectal cancer.
Hochster H, Kettner E, Kroning H, Becker K, Lordick F, Ramanathan RK, Macdonald J,
Hong S, John W, Schmoll HJ.
Clin Colorectal Cancer. 2005 Nov;5(4):257-62.
PMID:
16356302
Similar articles
Select item 16325695 169.
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-
cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk
breast cancer: results of a multicentre phase III trial.
Nitz UA, Mohrmann S, Fischer J, Lindemann W, Berdel WE, Jackisch C, Werner C, Ziske C,
Kirchner H, Metzner B, Souchon R, Ruffert U, Schütt G, Pollmanns A, Schmoll HJ,
Middecke C, Baltzer J, Schrader I, Wiebringhaus H, Ko Y, Rösel S, Schwenzer T, Wernet P,
Hinke A, Bender HG, Frick M; West German Study Group..
Lancet. 2005 Dec 3;366(9501):1935-44. Erratum in: Lancet. 2006 Mar 4;367(9512):730.
PMID:
16325695
Similar articles
Select item 16301834 170.
The future development of bevacizumab in colorectal cancer.
Díaz-Rubio E, Schmoll HJ.
Oncology. 2005;69 Suppl 3:34-45. Epub 2005 Nov 21. Review.
PMID:
16301834
Similar articles
Select item 16301829 171.
Introduction. Critical role of anti-angiogenesis and VEGF inhibition in colorectal cancer.
Díaz-Rubio E, Schmoll HJ.
Oncology. 2005;69 Suppl 3:1-3. Epub 2005 Nov 21. Review. No abstract available.
PMID:
16301829
Similar articles
Select item 16298522 172.
Does a patient's self-reported health-related quality of life predict survival beyond key
biomedical data in advanced colorectal cancer?
Efficace F, Bottomley A, Coens C, Van Steen K, Conroy T, Schöffski P, Schmoll H, Van
Cutsem E, Köhne CH.
Eur J Cancer. 2006 Jan;42(1):42-9. Epub 2005 Nov 18. Erratum in: Eur J Cancer. 2007
Feb;43(3):633.
PMID:
16298522
Similar articles
Select item 16254023 173.
Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German
Testicular Cancer Study Group (GTCSG).
Krege S, Boergermann C, Baschek R, Hinke A, Pottek T, Kliesch S, Dieckmann KP, Albers
P, Knutzen B, Weinknecht S, Schmoll HJ, Beyer J, Ruebben H; German Testicular Cancer
Study Group (GTCSG)..
Ann Oncol. 2006 Feb;17(2):276-80. Epub 2005 Oct 27.
PMID:
16254023
Similar articles
Select item 16234294 174.
Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line
salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory
germ-cell cancer.
Voigt W, Kegel T, Maher G, Jordan K, Müller L, Schmoll HJ.
Ann Oncol. 2006 Mar;17(3):531-3. Epub 2005 Oct 18. No abstract available.
PMID:
16234294
Similar articles
Select item 16192596 175.
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal
cancer.
Poston GJ, Adam R, Alberts S, Curley S, Figueras J, Haller D, Kunstlinger F, Mentha G,
Nordlinger B, Patt Y, Primrose J, Roh M, Rougier P, Ruers T, Schmoll HJ, Valls C, Vauthey
NJ, Cornelis M, Kahan JP.
J Clin Oncol. 2005 Oct 1;23(28):7125-34.
PMID:
16192596
Similar articles
Select item 16021466 176.
Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.
Voigt W, Kegel T, Weiss M, Mueller T, Simon H, Schmoll HJ.
J Cancer Res Clin Oncol. 2005 Sep;131(9):585-90. Epub 2005 Oct 20.
PMID:
16021466
Similar articles
Select item 15980649 177.
Age influences the expression of GAP-43 in the rat hippocampus following seizure.
Schmoll H, Ramboiu S, Platt D, Herndon JG, Kessler Ch, Popa-Wagner A.
Gerontology. 2005 Jul-Aug;51(4):215-24.
PMID:
15980649
Similar articles
Select item 15958444 178.
(Neo-)adjuvant treatments in colorectal cancer.
Arnold D, Schmoll HJ.
Ann Oncol. 2005;16 Suppl 2:ii133-40. Review. No abstract available.
PMID:
15958444
Similar articles
Select item 15928070 179.
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing
first-line platinum chemotherapy for advanced germ cell tumours.
Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R, Theodore C, Lelli G, Siegert W,
Horwich A, Marangolo M, Linkesch W, Pizzocaro G, Schmoll HJ, Bouzy J, Droz JP, Biron P;
Genito-Urinary Group of the French Federation of Cancer Centers (GETUG-FNCLCC),
France.; European Group for Blood and Marrow Transplantation (EBMT)..
Ann Oncol. 2005 Jul;16(7):1152-9. Epub 2005 May 31.
PMID:
15928070
Similar articles
Select item 15912837 180.
[Improving longevity in advanced intestinal cancer].
Schmoll HJ.
Krankenpfl J. 2005;43(1-3):48. German. No abstract available.
PMID:
15912837
Similar articles
181.
Resistance mechanisms following cisplatin and oxaliplatin treatment of the human
teratocarcinoma cell line 2102EP.
Rennicke A, Voigt W, Mueller T, Fruehauf A, Schmoll HJ, Beyer C, Dempke W.
Anticancer Res. 2005 Mar-Apr;25(2A):1147-55.
PMID:
15868958
Free Article
Similar articles
Select item 15855811 182.
Cancer-related anemia: pathogenesis, prevalence and treatment.
Birgegård G, Aapro MS, Bokemeyer C, Dicato M, Drings P, Hornedo J, Krzakowski M,
Ludwig H, Pecorelli S, Schmoll H, Schneider M, Schrijvers D, Shasha D, Van Belle S.
Oncology. 2005;68 Suppl 1:3-11. Review.
PMID:
15855811
Similar articles
Select item 15846560 183.
[S3-guideline conference "Colorectal Cancer" 2004].
Schmiegel W, Pox C, Adler G, Fleig W, Fölsch UR, Frühmorgen P, Graeven U, Hohenberger
W, Holstege A, Kühlbacher T, Porschen R, Propping P, Riemann JF, Sauer R, Sauerbruch T,
Schmoll HJ, Zeitz M, Selbmann HK; Deutschen Gesellschaft für Verdauungs- und
Stoffwechselkrankheiten.; Deutschen Krebshilfe.; Deutschen Krebsgesellschaft.; Deutschen
Gesellschaft für Hämatologie une Onkologie.; Deutschen Gesellschaft für Innere Medizin.;
Deutschen Gesellschaft für Koloproctologie.; Deutschen Gesellschaft für Pathologie.;
Deutschen Gesellschaft für Radioonkologie.; Deutschen Gesellschaft für Viszeralchirurgie.;
Deutschen Röntgengesellschaft.; Deutschen vereinten Gesellschaft für klinische Chemie und
Laboratoriumsmedizin e.V..
Dtsch Med Wochenschr. 2005 Apr 8;130 Suppl 1:S5-53. Review. German. No abstract
available.
PMID:
15846560
Similar articles
Select item 15693798 184.
Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab
monotherapy.
Jordan K, Grothey A, Grothe W, Kegel T, Wolf HH, Schmoll HJ.
Eur J Haematol. 2005 Mar;74(3):263-6.
PMID:
15693798
Similar articles
Select item 15668744 185.
Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: a
pooled analysis.
Jordan K, Hinke A, Grothey A, Schmoll HJ.
Support Care Cancer. 2005 Jan;13(1):26-31. Epub 2004 Nov 18.
PMID:
15668744
Similar articles
Select item 15661543 186.
Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic
prophylaxis and treatment.
Jordan K, Kasper C, Schmoll HJ.
Eur J Cancer. 2005 Jan;41(2):199-205. Review.
PMID:
15661543
Similar articles
Select item 15619172 187.
[Extravasation of chemotherapeutic agents: prevention and therapy].
Jordan K, Grothe W, Schmoll HJ.
Dtsch Med Wochenschr. 2005 Jan 7;130(1-2):33-7. German.
PMID:
15619172
Similar articles
Select item 15508058 188.
[S3-Guidelines Conference "Colorectal Carcinoma" 2004].
Schmiegel W, Pox C, Adler G, Fleig W, Fölsch UR, Frühmorgen P, Graeven U, Hohenberger
W, Holstege A, Junginger T, Kühlbacher T, Porschen R, Propping P, Riemann JF, Sauer R,
Sauerbruch T, Schmoll HJ, Zeitz M, Selbmann HK; Deutschen Gesellschaft für Verdauungs..
Z Gastroenterol. 2004 Oct;42(10):1129-77. German. No abstract available.
PMID:
15508058
Similar articles
Select item 15493037 189.
A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the
treatment of metastatic spinal cord compression: final results of a multicenter study.
Rades D, Fehlauer F, Stalpers LJ, Wildfang I, Zschenker O, Schild SE, Schmoll HJ, Karstens
JH, Alberti W.
Cancer. 2004 Dec 1;101(11):2687-92.
PMID:
15493037
Free Article
Similar articles
Select item 15319245 190.
European consensus on diagnosis and treatment of germ cell cancer: a report of the European
Germ Cell Cancer Consensus Group (EGCCCG).
Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD,
Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH,
Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba
F, Bamberg M, Bodrogi I, Bokemeyer C, Classen J, Clemm S, Culine S, de Wit M, Derigs
HG, Dieckmann KP, Flasshove M, Garcia del Muro X, Gerl A, Germa-Lluch JR, Hartmann
M, Heidenreich A, Hoeltl W, Joffe J, Jones W, Kaiser G, Klepp O, Kliesch S, Kisbenedek L,
Koehrmann KU, Kuczyk M, Laguna MP, Leiva O, Loy V, Mason MD, Mead GM, Mueller
RP, Nicolai N, Oosterhof GO, Pottek T, Rick O, Schmidberger H, Sedlmayer F, Siegert W,
Studer U, Tjulandin S, von der Maase H, Walz P, Weinknecht S, Weissbach L, Winter E,
Wittekind C; European Germ Cell Cancer Consensus Group..
Ann Oncol. 2004 Sep;15(9):1377-99. Review.
PMID:
15319245
Similar articles
Select item 23570153 191.
[Oxaliplatin (Eloxatin). Progress in tumor therapy. 2004. Introduction].
Schmoll HJ.
Onkologie. 2004 Aug;27 Suppl 1:1. German. No abstract available.
PMID:
23570153
Similar articles
Select item 15266338 192.
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based
combination chemotherapy: a pooled analysis of two randomised trials.
Bokemeyer C, Kollmannsberger C, Stenning S, Hartmann JT, Horwich A, Clemm C, Gerl A,
Meisner C, Rückerl CP, Schmoll HJ, Kanz L, Oliver T.
Br J Cancer. 2004 Aug 16;91(4):683-7.
PMID:
15266338
Free PMC Article
Similar articles
Select item 15207020 193.
Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced
gastrointestinal cancers.
Jordan K, Kellner O, Kegel T, Schmoll HJ, Grothey A.
Clin Colorectal Cancer. 2004 May;4(1):46-50.
PMID:
15207020
Similar articles
Select item 15160289 194.
Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats.
Fittkau M, Voigt W, Holzhausen HJ, Schmoll HJ.
J Cancer Res Clin Oncol. 2004 Jul;130(7):388-94.
PMID:
15160289
Similar articles
Select item 15156346 195.
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients
with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer
JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D,
Ganser A.
Ann Hematol. 2004 Aug;83(8):498-503. Epub 2004 May 20.
PMID:
15156346
Similar articles
Select item 15051767 196.
Survival of patients with advanced colorectal cancer improves with the availability of
fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.
Grothey A, Sargent D, Goldberg RM, Schmoll HJ.
J Clin Oncol. 2004 Apr 1;22(7):1209-14.
PMID:
15051767
Similar articles
Select item 15009517 197.
Observations on experimental marginal periodontitis in rats.
Kuhr A, Popa-Wagner A, Schmoll H, Schwahn C, Kocher T.
J Periodontal Res. 2004 Apr;39(2):101-6.
PMID:
15009517
Similar articles
Select item 23573556 198.
The evolving role of oxaliplatin in the management of colorectal cancer.
de Gramont A, Schmoll HJ, Cervantes A, Tournigand C.
Colorectal Dis. 2003 Nov;5 Suppl 3:10-9. Review.
PMID:
23573556
Similar articles
Select item 14568987 199.
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin
chemotherapy plus autologous stem cell support for patients with advanced metastatic germ
cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P,
Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C;
German Testicular Cancer Study Group..
J Clin Oncol. 2003 Nov 15;21(22):4083-91. Epub 2003 Oct 20.
PMID:
14568987
Similar articles
Select item 14551502 200.
Dihydropyrimidine dehydrogenase inhibition as a strategy for the oral administration of 5-
fluorouracil: utility in the treatment of advanced colorectal cancer.
Schmoll HJ.
Anticancer Drugs. 2003 Oct;14(9):695-702. Review.
PMID:
14551502
Similar articles
201.
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion
with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal
cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group
Study 40952.
Köhne CH, Wils J, Lorenz M, Schöffski P, Voigtmann R, Bokemeyer C, Lutz M, Kleeberg C,
Ridwelski K, Souchon R, El-Serafi M, Weiss U, Burkhard O, Rückle H, Lichnitser M,
Langenbuch T, Scheithauer W, Baron B, Couvreur ML, Schmoll HJ; European Organization
of Research and Treatment of Cancer Gastrointestinal Group Study 40952..
J Clin Oncol. 2003 Oct 15;21(20):3721-8. Epub 2003 Sep 8.
PMID:
12963704
Similar articles
Select item 12915600 202.
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
Rödel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R.
J Clin Oncol. 2003 Aug 15;21(16):3098-104.
PMID:
12915600
Similar articles
Select item 12871101 203.
Biomolecules linked to transition metal complexes--new chances for chemotherapy.
Paschke R, Paetz C, Mueller T, Schmoll HJ, Mueller H, Sorkau E, Sinn E.
Curr Med Chem. 2003 Oct;10(19):2033-44. Review.
PMID:
12871101
Similar articles
Select item 12838296 204.
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients
with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Bokemeyer C, Schleucher N, Metzner B, Thomas M, Rick O, Schmoll HJ, Kollmannsberger
C, Boehlke I, Kanz L, Hartmann JT.
Br J Cancer. 2003 Jul 7;89(1):29-35.
PMID:
12838296
Free PMC Article
Similar articles
Select item 12667704 205.
Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery:
synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic
properties with corresponding cisplatin compounds.
Paschke R, Kalbitz J, Paetz C, Luckner M, Mueller T, Schmoll HJ, Mueller H, Sorkau E, Sinn
E.
J Inorg Biochem. 2003 Apr 1;94(4):335-42.
PMID:
12667704
Similar articles
Select item 12651203 206.
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary
high-dose chemotherapy plus autologous stem cell support.
Kollmannsberger C, Schleucher N, Rick O, Metzner B, Hartmann JT, Schöffski P, Beyer J,
Casper J, Sosada M, Schmoll HJ, Böhlke I, Meisner C, Kanz L, Bokemeyer C.
Eur J Cancer. 2003 Apr;39(6):775-82.
PMID:
12651203
Similar articles
Select item 12598335 207.
Kindling status in sprague-dawley rats induced by pentylenetetrazole: involvement of a
critical development period.
Schmoll H, Badan I, Grecksch G, Walker L, Kessler C, Popa-Wagner A.
Am J Pathol. 2003 Mar;162(3):1027-34.
PMID:
12598335
Free PMC Article
Similar articles
Select item 12543810 208.
Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin
resistance in testicular cancer.
Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
Cancer Res. 2003 Jan 15;63(2):513-21.
PMID:
12543810
Free Article
Similar articles
Select item 12422306 209.
The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects
and future directions.
Schmoll HJ.
Semin Oncol. 2002 Oct;29(5 Suppl 15):34-9. Review.
PMID:
12422306
Similar articles
Select item 12401700 210.
Extragonadal germ cell tumors.
Schmoll HJ.
Ann Oncol. 2002;13 Suppl 4:265-72. Review. No abstract available.
PMID:
12401700
Similar articles
Select item 12110487 211.
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third
International Conference: Perspectives in Colorectal Cancer, Dublin, 2001).
Van Cutsem E, Dicato M, Wils J, Cunningham D, Diaz-Rubio E, Glimelius B, Haller D,
Johnston P, Kerr D, Koehne CH, Labianca R, Minsky B, Nordlinger B, Roth A, Rougier P,
Schmoll HJ.
Eur J Cancer. 2002 Jul;38(11):1429-36.
PMID:
12110487
Similar articles
Select item 12078387 212.
[Deficits in management of patients with colorectal carcinoma in Germany. Results of
multicenter documentation of therapy algorithms].
Grothey A, Kellermann L, Schmoll HJ.
Med Klin (Munich). 2002 May 15;97(5):270-7. German.
PMID:
12078387
Similar articles
Select item 12006767 213.
A new chemoembolization protocol in refractory liver metastasis of colorectal cancer--a
feasibility study.
Voigt W, Behrmann C, Schlueter A, Kegel T, Grothey A, Schmoll HJ.
Onkologie. 2002 Apr;25(2):158-64.
PMID:
12006767
Similar articles
Select item 11999557 214.
Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute
myeloid leukemia-results of a phase I-II study.
Mantovani L, Hasenclever D, Krahl R, Pönisch W, Herold M, Pasold R, Fiedler F, Dölken G,
Kämpfe D, Schmoll HJ, Súbert R, Kubel M, Niederwieser D, Helbig W; East German
Hematology and Oncology Group (OSHO)..
Leuk Lymphoma. 2002 Feb;43(2):265-74.
PMID:
11999557
Similar articles
Select item 11983090 215.
Detection of an occult B-cell lymphoma in the donor's bone marrow prior to HLA-matched
sibling transplantation.
Krüger WH, Wolf HH, Voigt W, Skibbe T, Schmoll HJ.
J Hematother Stem Cell Res. 2002 Apr;11(2):169-70. No abstract available.
PMID:
11983090
Similar articles
Select item 11919246 216.
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an
international analysis.
Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J,
Pont J, Kanz L, Einhorn L, Hartmann JT.
J Clin Oncol. 2002 Apr 1;20(7):1864-73.
PMID:
11919246
Similar articles
Select item 11862477 217.
Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage
of the intestinal luminal mucosa.
Fittkau M, Gerlach R, Schmoll HJ.
J Cancer Res Clin Oncol. 2002 Feb;128(2):80-4. Epub 2001 Nov 21.
PMID:
11862477
Similar articles
Select item 11856588 218.
Is there a role of high-dose chemotherapy in lymphoma and solid tumours: the present state of
the art.
Schmoll HJ.
Crit Rev Oncol Hematol. 2002 Feb;41(2):127-8. No abstract available.
PMID:
11856588
Similar articles
Select item 11822762 219.
Localised disease in cancer of unknown primary (CUP): the value of positron emission
tomography (PET) for individual therapeutic management.
Rades D, Kühnel G, Wildfang I, Börner AR, Schmoll HJ, Knapp W.
Ann Oncol. 2001 Nov;12(11):1605-9.
PMID:
11822762
Similar articles
Select item 11713391 220.
Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of
an update conference on evidence-based medicine (EBM).
Krege S, Souchon R, Schmoll HJ; German Testicular Cancer Study Group..
Eur Urol. 2001 Oct;40(4):372-91. Review. No abstract available.
PMID:
11713391
Similar articles
221.
Integrating oxaliplatin into the management of colorectal cancer.
Schmoll HJ, Cassidy J.
Oncologist. 2001;6 Suppl 4:24-8. Review.
PMID:
11585971
Free Article
Similar articles
Select item 11585968 222.
The evolution of fluoropyrimidine therapy: from intravenous to oral.
Hoff PM, Cassidy J, Schmoll HJ.
Oncologist. 2001;6 Suppl 4:3-11. Review.
PMID:
11585968
Free Article
Similar articles
Select item 11560047 223.
[Possible new indications for erythropoietin therapy].
Dempke W, Schmoll HJ.
Med Klin (Munich). 2001 Aug 15;96(8):467-74. Review. German.
PMID:
11560047
Similar articles
Select item 11469682 224.
Protective effect of oral phosphatidylcholine on radiation-induced release of intestinal
peptidases in rats.
Fittkau M, Gerlach R, Schmoll HJ.
J Cancer Res Clin Oncol. 2001 Jul;127(7):444-8.
PMID:
11469682
Similar articles
Select item 11469677 225.
Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W, Rie C, Grothey A, Schmoll HJ.
J Cancer Res Clin Oncol. 2001 Jul;127(7):411-7. Review.
PMID:
11469677
Similar articles
Select item 11441270 226.
[Interdisciplinary onsensus on Diagnosis and Treatment of Testicular Germ Cell Tumors:
Result of an Update-onference on Evidence-Based Medicine]
Schmoll HJ, Krege S, Souchon R.
Onkologie. 2000 Dec;23(6):603-613.
PMID:
11441270
Similar articles
Select item 11429486 227.
New chemotherapy approaches in colorectal cancer.
Grothey A, Schmoll HJ.
Curr Opin Oncol. 2001 Jul;13(4):275-86. Review.
PMID:
11429486
Similar articles
Select item 11395167 228.
Dynamics of gene expression for immediate early- and late genes after seizure activity in aged
rats.
Schmoll H, Badan I, Fischer B, Wagner AP.
Arch Gerontol Geriatr. 2001 Jun;32(3):199-218.
PMID:
11395167
Similar articles
Select item 11352956 229.
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ
cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an
international study group.
Fizazi K, Tjulandin S, Salvioni R, Germà-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl
A, Fléchon A, de Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M,
Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Théodore C, Hartmann JT, Schmoll HJ,
Kaye SB, Culine S, Droz JP, Mahé C.
J Clin Oncol. 2001 May 15;19(10):2647-57.
PMID:
11352956
Similar articles
Select item 11326688 230.
Human hematopoietic growth factors: old lessons and new perspectives.
Dempke W, Von Poblozki A, Grothey A, Schmoll HJ.
Anticancer Res. 2000 Nov-Dec;20(6D):5155-64. Review.
PMID:
11326688
Similar articles
Select item 11326684 231.
HCG induced hyperthyreosis in germ cell cancer.
Kellner O, Voigt W, Schneyer U, Dempke W, Schmoll HJ.
Anticancer Res. 2000 Nov-Dec;20(6D):5135-8.
PMID:
11326684
Similar articles
Select item 11315589 232.
[Interdisciplinary consensus in diagnosis and therapy of testicular tumors. Results of an
update conference founded on evidence-based medicine (EBM)].
Krege S, Schmoll HJ, Souchon R.
Urologe A. 2001 Mar;40(2):137-47. Review. German. No abstract available.
PMID:
11315589
Similar articles
Select item 11283942 233.
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long
term treatment outcome.
Bokemeyer C, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Schmoll HJ, Kanz L,
Einhorn L, Nichols CR, Hartmann JT.
Cancer. 2001 Apr 1;91(7):1394-401.
PMID:
11283942
Similar articles
Select item 11250992 234.
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell
tumors: results of an international multicenter analysis.
Hartmann JT, Einhorn L, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont
J, Schmoll HJ, Kanz L, Bokemeyer C.
J Clin Oncol. 2001 Mar 15;19(6):1641-8.
PMID:
11250992
Similar articles
Select item 11216920 235.
A low dose of ionizing radiation increases luminal release of intestinal peptidases in rats.
Fittkau M, Grothey A, Gerlach R, Schmoll HJ.
J Cancer Res Clin Oncol. 2001 Feb;127(2):96-100.
PMID:
11216920
Similar articles
Select item 11204317 236.
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Dempke W, von Poblozki A, Kellner O, Wolf HH, Schmoll HJ.
Wien Klin Wochenschr. 2000 Dec 22;112(24):1053-8. German.
PMID:
11204317
Similar articles
Select item 11134198 237.
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin,
etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or
refractory germ cell cancer.
Rick O, Bokemeyer C, Beyer J, Hartmann JT, Schwella N, Kingreen D, Neureither S,
Metzner B, Casper J, Wandt H, Hartmann F, Schmoll HJ, Derigs G, Gerl A, Berdel WE, Kanz
L, Siegert W.
J Clin Oncol. 2001 Jan 1;19(1):81-8.
PMID:
11134198
Similar articles
Select item 11113603 238.
Brain plasticity: to what extent do aged animals retain the capacity to coordinate gene activity
in response to acute challenges.
Wagner AP, Schmoll H, Badan I, Platt D, Kessler C.
Exp Gerontol. 2000 Dec;35(9-10):1211-27.
PMID:
11113603
Similar articles
Select item 11050912 239.
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an
update conference based on evidence-based medicine. German Testicular Cancer study Group
(GTCSG)].
Souchon R, Krege S, Schmoll HJ, Albers P, Beyer J, Bokemeyer C, Classen J, Dieckmann
KP, Hartmann M, Heidenreich A, Höltl W, Kliesch S, Köhrmann KU, Kuczyk M,
Schmidberger H, Weinknecht S, Winter E, Wittekind C, Bamberg M.
Strahlenther Onkol. 2000 Sep;176(9):388-405. Review. German.
PMID:
11050912
Similar articles
Select item 10985069 240.
[Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].
von Poblozki A, Dempke W, Schmoll HJ.
Med Klin (Munich). 2000 Aug 15;95(8):457-60. German.
PMID:
10985069
Similar articles
241.
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell
cancer and brain metastases.
Kollmannsberger C, Nichols C, Bamberg M, Hartmann JT, Schleucher N, Beyer J, Schöfski
P, Derigs G, Rüther U, Böhlke I, Schmoll HJ, Kanz L, Bokemeyer C.
Ann Oncol. 2000 May;11(5):553-9.
PMID:
10907948
Similar articles
Select item 10898536 242.
Cisplatin resistance and oncogenes--a review.
Dempke W, Voigt W, Grothey A, Hill BT, Schmoll HJ.
Anticancer Drugs. 2000 Apr;11(4):225-36. Review.
PMID:
10898536
Similar articles
Select item 10894863 243.
Final results of a randomized phase III trial of sequential high-dose methotrexate,
fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional
fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for
Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, Van Cutsem E, Planker M,
Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B,
Couvreur ML, Baron B, Wils JA.
J Clin Oncol. 2000 Jul;18(14):2648-57.
PMID:
10894863
Similar articles
Select item 10885902 244.
Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin.
Dempke W, Voigt W, Grothey A, Schmoll HJ.
Anticancer Drugs. 1999 Jul;10(6):545-9.
PMID:
10885902
Similar articles
Select item 10819311 245.
Delayed and blunted induction of mRNA for tissue plasminogen activator in the brain of old
rats following pentylenetetrazole-induced seizure activity.
Popa-Wagner A, Fischer B, Platt D, Schmoll H, Kessler C.
J Gerontol A Biol Sci Med Sci. 2000 May;55(5):B242-8.
PMID:
10819311
Similar articles
Select item 10815936 246.
Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid
cancer cell lines.
Voigt W, Bulankin A, Müller T, Schoeber C, Grothey A, Hoang-Vu C, Schmoll HJ.
Clin Cancer Res. 2000 May;6(5):2087-93.
PMID:
10815936
Free Article
Similar articles
Select item 10766557 247.
Manic episode in an ifosfamide-treated patient.
Brieger P, Marneros A, Wolf HH, Schmoll HJ.
Gen Hosp Psychiatry. 2000 Jan-Feb;22(1):52-3. No abstract available.
PMID:
10766557
Similar articles
Select item 10689748 248.
[Colorectal carcinoma: prevention and early detection in an asymptomatic population--
prevention in patients at risk--endoscopic diagnosis, therapy and after-care of polyps and
carcinomas. German Society of Digestive and Metabolic Diseases/Study Group for
Gastrointestinal Oncology].
Schmiegel W, Adler G, Frühmorgen P, Fölsch U, Graeven U, Layer P, Petrasch S, Porschen
R, Pox C, Sauerbruch T, Schmoll HJ, Zeitz M.
Z Gastroenterol. 2000 Jan;38(1):49-75. German. No abstract available.
PMID:
10689748
Similar articles
Select item 10681261 249.
[Active specific immunotherapy (ASI) in colon cancer].
Schmoll HJ.
Strahlenther Onkol. 2000 Jan;176(1):47-8. German. No abstract available.
PMID:
10681261
Similar articles
Select item 10641510 250.
[Diagnostic and therapeutic management of the superior vena cava syndrome].
Dempke W, Behrmann C, Schöber C, Büchele T, Grothey A, Schmoll HJ.
Med Klin (Munich). 1999 Dec 15;94(12):681-4. Review. German.
PMID:
10641510
Similar articles
Select item 10597209 251.
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular
Cancer Study Group (GTCSG).
Bokemeyer C, Kollmannsberger C, Harstrick A, Beyer J, Gerl A, Casper J, Metzner B,
Hartmann JT, Schmoll HJ, Kanz L.
Int J Cancer. 1999 Dec 10;83(6):848-51.
PMID:
10597209
Free Article
Similar articles
Select item 10606252 252.
Where do we stand with 5-fluorouracil?
Schmoll HJ, Büchele T, Grothey A, Dempke W.
Semin Oncol. 1999 Dec;26(6):589-605. Review.
PMID:
10606252
Similar articles
Select item 10602058 253.
UICC symposium on testicular cancer: Guidelines for standard care and future prospects.
Bokemeyer C, Bamberg M, Albers J, Schmoll H, Weissbach L.
Int J Cancer. 1999 Dec 10;83(6):808. No abstract available.
PMID:
10602058
Free Article
Similar articles
Select item 10579203 254.
Anomalous expression of microtubule-associated protein 1B in the hippocampus and cortex
of aged rats treated with pentylenetetrazole.
Popa-Wagner A, Fischer B, Platt D, Neubig R, Schmoll H, Kessler C.
Neuroscience. 1999;94(2):395-403.
PMID:
10579203
Similar articles
Select item 10579082 255.
Treatment of testicular tumours based on risk factors.
Schmoll HJ.
Curr Opin Urol. 1999 Sep;9(5):431-8. Review.
PMID:
10579082
Similar articles
Select item 10550141 256.
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in
patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
Bokemeyer C, Kollmannsberger C, Meisner C, Harstrick A, Beyer J, Metzner B, Hartmann
JT, Schmoll HJ, Einhorn L, Kanz L, Nichols C.
J Clin Oncol. 1999 Nov;17(11):3450-6.
PMID:
10550141
Similar articles
Select item 10520310 257.
[Glucose infusions--a possible effective therapeutic option in ifosfamide-induced
encephalopathy].
Kellner O, Dempke W, Schmoll HJ.
Dtsch Med Wochenschr. 1999 Sep 17;124(37):1086-7. German. No abstract available.
PMID:
10520310
Similar articles
Select item 10360658 258.
Long-term effects on sexual function and fertility after treatment of testicular cancer.
Hartmann JT, Albrecht C, Schmoll HJ, Kuczyk MA, Kollmannsberger C, Bokemeyer C.
Br J Cancer. 1999 May;80(5-6):801-7.
PMID:
10360658
Free PMC Article
Similar articles
Select item 10235470 259.
The role of insulin-like growth factor I and its receptor in cell growth, transformation,
apoptosis, and chemoresistance in solid tumors.
Grothey A, Voigt W, Schöber C, Müller T, Dempke W, Schmoll HJ.
J Cancer Res Clin Oncol. 1999;125(3-4):166-73. Review.
PMID:
10235470
Similar articles
Select item 10197512 260.
Upregulation of MAP1B and MAP2 in the rat brain after middle cerebral artery occlusion:
effect of age.
Popa-Wagner A, Schröder E, Schmoll H, Walker LC, Kessler C.
J Cereb Blood Flow Metab. 1999 Apr;19(4):425-34.
PMID:
10197512
Similar articles
261.
Treatment outcome of patients with brain metastases from malignant germ cell tumors.
Fosså SD, Bokemeyer C, Gerl A, Culine S, Jones WG, Mead GM, Germa-Luch JR, Pont J,
Schmoll HJ, Tjulandin S.
Cancer. 1999 Feb 15;85(4):988-97.
PMID:
10091779
Similar articles
Select item 10080593 262.
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
Bokemeyer C, Gerl A, Schöffski P, Harstrick A, Niederle N, Beyer J, Casper J, Schmoll HJ,
Kanz L.
J Clin Oncol. 1999 Feb;17(2):512-6.
PMID:
10080593
Similar articles
Select item 10023302 263.
Is there a standard adjuvant treatment for rectal cancer?
Tveit KM, Nordlinger B, Penna C, Schmoll HJ.
Eur J Cancer. 1998 Nov;34(12):1827-35. Review. No abstract available.
PMID:
10023302
Similar articles
Select item 9893648 264.
Is there a standard adjuvant treatment for colon cancer?
Slevin ML, Papamichael D, Rougier P, Schmoll HJ.
Eur J Cancer. 1998 Oct;34(11):1652-63. No abstract available.
PMID:
9893648
Similar articles
Select item 9829732 265.
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced
solid tumors.
Korfel A, Scheulen ME, Schmoll HJ, Gründel O, Harstrick A, Knoche M, Fels LM, Skorzec
M, Bach F, Baumgart J, Sass G, Seeber S, Thiel E, Berdel WE.
Clin Cancer Res. 1998 Nov;4(11):2701-8.
PMID:
9829732
Free Article
Similar articles
Select item 9779717 266.
Secondary leukemia following high cumulative doses of etoposide in patients treated for
advanced germ cell tumors.
Kollmannsberger C, Beyer J, Droz JP, Harstrick A, Hartmann JT, Biron P, Fléchon A,
Schöffski P, Kuczyk M, Schmoll HJ, Kanz L, Bokemeyer C.
J Clin Oncol. 1998 Oct;16(10):3386-91.
PMID:
9779717
Similar articles
Select item 9750020 267.
Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in
human non-seminomatous germ cell tumour cell lines.
Dunn TA, Schmoll HJ, Rie C, Hartmann K, Casper J.
J Cancer Res Clin Oncol. 1998;124(8):435-43.
PMID:
9750020
Similar articles
Select item 9663421 268.
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in
patients with progressive or recurrent colorectal cancer? A phase II study.
Hartmann JT, Köhne CH, Schmoll HJ, Daikeler T, Kanz L, Bokemeyer C.
Oncology. 1998 Jul-Aug;55(4):320-5.
PMID:
9663421
Similar articles
Select item 9624243 269.
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver
metastases.
Hartmann JT, Schmoll E, Bokemeyer C, Fety R, Lucas C, Giroux B, Schmoll HJ.
Eur J Cancer. 1998 Jan;34(1):87-91.
PMID:
9624243
Similar articles
Select item 9579846 270.
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz
L.
Br J Cancer. 1998 Apr;77(8):1355-62.
PMID:
9579846
Free PMC Article
Similar articles
Select item 9578059 271.
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous
testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs
HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A,
Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H,
Kanz L, Schmoll HJ.
Semin Oncol. 1998 Apr;25(2 Suppl 4):24-32; discussion 45-8. Review.
PMID:
9578059
Similar articles
Select item 9562450 272.
Prognostic factors in metastatic germ cell tumors.
Schmoll HJ, Beyer J.
Semin Oncol. 1998 Apr;25(2):174-85. Review.
PMID:
9562450
Similar articles
Select item 9512009 273.
Altered expression of microtubule-associated protein 1B in cerebral cortical structures of
pentylenetetrazole-treated rats.
Wagner AP, Fischer B, Schmoll H, Platt D, Kessler C.
J Neurosci Res. 1998 Mar 1;51(5):646-57.
PMID:
9512009
Similar articles
Select item 9470854 274.
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate
in patients with advanced colorectal cancer. Results of a phase II study.
Köhne CH, Harstrick A, Hiddemann W, Schöffski P, Wilke H, Bokemeyer C, Dörken B,
Schmoll HJ.
Eur J Cancer. 1997 Oct;33(11):1896-9.
PMID:
9470854
Similar articles
Select item 9469324 275.
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly
24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
Köhne CH, Schöffski P, Wilke H, Käufer C, Andreesen R, Ohl U, Klaasen U, Westerhausen
M, Hiddemann W, Schott G, Harstick A, Bade J, Horster A, Schubert U, Hecker H, Dörken
B, Schmoll HJ.
J Clin Oncol. 1998 Feb;16(2):418-26.
PMID:
9469324
Similar articles
Select item 9420627 276.
Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas:
evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by
IFN-gamma.
Seliger B, Dunn T, Schwenzer A, Casper J, Huber C, Schmoll HJ.
Scand J Immunol. 1997 Dec;46(6):625-32.
PMID:
9420627
Free Article
Similar articles
Select item 9413228 277.
Evaluation of topoisomerase I catalytic activity as determinant of drug response in human
cancer cell lines.
Voigt W, Vanhoefer U, Yin MB, Minderman H, Schmoll HJ, Rustum YM.
Anticancer Res. 1997 Sep-Oct;17(5A):3707-11.
PMID:
9413228
Similar articles
Select item 9398451 278.
Increased expression of microtubule-associated protein 1B in the hippocampus, subiculum,
and perforant path of rats treated with a high dose of pentylenetetrazole.
Popa-Wagner A, Fischer B, Schmoll H, Platt D, Kessler C.
Exp Neurol. 1997 Nov;148(1):73-82.
PMID:
9398451
Similar articles
Select item 9358946 279.
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate
(PALA) is inactive in advanced pancreatic carcinoma.
Harstrick A, Köhne CH, Hiddemann W, Preusser P, Strumberg D, Berns T, Seeber S, Wilke
H, Schmoll HJ.
Ann Oncol. 1997 Sep;8(9):917-8.
PMID:
9358946
Similar articles
Select item 9317171 280.
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with
peripheral blood stem cell support for the treatment of patients with advanced soft tissue
sarcomas.
Bokemeyer C, Franzke A, Hartmann JT, Schöber C, Arseniev L, Metzner B, Link H, Kanz L,
Schmoll HJ.
Cancer. 1997 Oct 1;80(7):1221-7.
PMID:
9317171
Similar articles
281.
Quantification of additional short arms of chromosome 12 in germ cell tumours using the
polymerase chain reaction.
Malek NP, Casper J, Looijenga LH, Strohmeyer T, Schmoll HJ, Nordheim A, Janknecht R.
Eur J Cancer. 1997 Aug;33(9):1488-94.
PMID:
9337694
Similar articles
Select item 9337672 282.
Prognostic factors for advanced seminoma--a solid basis for clinical trials.
Schmoll HJ.
Eur J Cancer. 1997 Aug;33(9):1347-50. No abstract available.
PMID:
9337672
Similar articles
Select item 9289856 283.
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors].
Bamberg M, Schmoll HJ, Weissbach L, Beyer J, Bokemeyer C, Harstrick A, Höltl W,
Souchon R, Vogler H.
Strahlenther Onkol. 1997 Aug;173(8):397-406. Review. German.
PMID:
9289856
Similar articles
Select item 9340905 284.
[Interdisciplinary consensus conference on "diagnosis and therapy of testicular tumors"].
Weissbach L, Bamberg M, Schmoll HJ.
Urologe A. 1997 Jul;36(4):362-8. Review. German. No abstract available.
PMID:
9340905
Similar articles
Select item 9261521 285.
Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular
germ cell tumors.
Hartmann JT, Schmoll HJ, Kuczyk MA, Candelaria M, Bokemeyer C.
Ann Oncol. 1997 Jun;8(6):531-8.
PMID:
9261521
Similar articles
Select item 9215791 286.
Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human
carcinoma cells.
Berkovic D, Gründel O, Berkovic K, Wildfang I, Hess CF, Schmoll HJ.
Radiother Oncol. 1997 Jun;43(3):293-301.
PMID:
9215791
Similar articles
Select item 9291803 287.
Comparison of histological results from the resection of residual masses at different sites after
chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT, Candelaria M, Kuczyk MA, Schmoll HJ, Bokemeyer C.
Eur J Cancer. 1997 May;33(6):843-7.
PMID:
9291803
Similar articles
Select item 9193339 288.
Treatment of brain metastases in patients with testicular cancer.
Bokemeyer C, Nowak P, Haupt A, Metzner B, Köhne H, Hartmann JT, Kanz L, Schmoll HJ.
J Clin Oncol. 1997 Apr;15(4):1449-54.
PMID:
9193339
Similar articles
Select item 9075778 289.
Phase II evaluation of 5-fluourouracil plus folinic acid and alpha 2b-interferon in metastatic
colorectal cancer.
Köhne CH, Wilke H, Hiddemann W, Bokemeyer C, Lohrmann HP, Bodenstein H, Preiss J,
Rauschecker H, Hill H, Kaufer C, Fischer JT, Ohl U, Urbanitz D, Balleisen L, Schmoll HJ.
Oncology. 1997 Mar-Apr;54(2):96-101.
PMID:
9075778
Similar articles
Select item 21590035 290.
Hepatic arterial infusion of the nitrosourea derivate fotemustine for the treatment of liver
metastases from colorectal carcinoma.
Hartmann J, Schmoll E, Bokemeyer C, Fety R, Lucas C, Dagay L, Schmoll H.
Oncol Rep. 1997 Jan-Feb;4(1):167-72.
PMID:
21590035
Similar articles
Select item 9220289 291.
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer
cell lines.
Dunn TA, Schmoll HJ, Grünwald V, Bokemeyer C, Casper J.
Invest New Drugs. 1997;15(2):109-14.
PMID:
9220289
Similar articles
Select item 9133102 292.
[Management of endocrine pancreatic tumors].
Schöber C, Galanski M, Jörgensen M, Schmoll HJ.
Wien Med Wochenschr. 1997;147(1):18-23. Review. German.
PMID:
9133102
Similar articles
Select item 9037359 293.
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide
and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell
tumors.
Bokemeyer C, Köhrmann O, Tischler J, Weissbach L, Räth U, Haupt A, Schöffski P,
Harstrick A, Schmoll HJ.
Ann Oncol. 1996 Dec;7(10):1015-21.
PMID:
9037359
Similar articles
Select item 8980410 294.
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or
ifosfamide anti-tumour activity.
Bokemeyer C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H, Lentzen H.
Br J Cancer. 1996 Dec;74(12):2036-41.
PMID:
8980410
Free PMC Article
Similar articles
Select item 9036294 295.
[Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis].
Bokemeyer C, Kuczyk MA, Köhne CH, Haupt A, Schmoll HJ.
Med Klin (Munich). 1996 Nov 15;91(11):703-10. Review. German. No abstract available.
PMID:
9036294
Similar articles
Select item 8918489 296.
Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ.
J Clin Oncol. 1996 Nov;14(11):2923-32.
PMID:
8918489
Similar articles
Select item 9229317 297.
The dead end of 5-fluorouracil double modulation and promise of continuous infusion
schedules in the treatment of metastatic colorectal cancer.
Köhne CH, Wilke H, Schöffski P, Schmoll HJ.
J Infus Chemother. 1996 Fall;6(4):206-10. Review. No abstract available.
PMID:
9229317
Similar articles
Select item 8874322 298.
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of
prognostic variables.
Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A,
Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W.
J Clin Oncol. 1996 Oct;14(10):2638-45.
PMID:
8874322
Similar articles
Select item 21594458 299.
Malignant fibrous histiocytoma of bone - Review of thirteen cases.
Hartmann J, Thiel I, Schmoll H, Einsele H, Kanz L, Bokemeyer C.
Oncol Rep. 1996 Sep;3(5):813-7.
PMID:
21594458
Similar articles
Select item 8949993 300.
Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of
testicular cancer.
Dunn TA, Schmoll HJ, Grünwald V, Bokemeyer C, Casper J.
Anticancer Drugs. 1996 Sep;7(7):795-9.
PMID:
8949993
Similar articles
301.
Sequential intermediate high-dose chemotherapy in the primary treatment of poor risk
testicular cancer.
Schmoll HJ, Bokemeyer C.
Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S48-9. No abstract available.
PMID:
8899172
Similar articles
Select item 9229322 302.
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric
cancer.
Wilke H, Korn M, Vanhöfer U, Fink U, Stahl M, Preusser P, Köhne C, Klassen U, Harstrick
A, Schmoll HJ, Seeber S.
J Infus Chemother. 1996 Summer;6(3):123-6.
PMID:
9229322
Similar articles
Select item 8647654 303.
Comparative analysis of cell surface antigens expressed by cell lines derived from human
germ cell tumours.
Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J, von Keitz A,
Looijenga LH, Millán JL, Oosterhuis JW, Pera M, Sawada M, Schmoll HJ, Skakkebaek NE,
van Putten W, Stern P.
Int J Cancer. 1996 Jun 11;66(6):806-16.
PMID:
8647654
Free Article
Similar articles
Select item 8692552 304.
Management of other non-cisplatin-induced emesis.
Schmoll HJ, Casper J.
Oncology. 1996 Jun;53 Suppl 1:51-5. Review.
PMID:
8692552
Similar articles
Select item 8624272 305.
Endocrinological late effects after chemotherapy for testicular cancer.
Berger CC, Bokemeyer C, Schuppert F, Schmoll HJ.
Br J Cancer. 1996 May;73(9):1108-14.
PMID:
8624272
Free PMC Article
Similar articles
Select item 8692125 306.
[Therapy of germ cell tumors. Model for interdisciplinary treatment approach].
Schmoll HJ.
Med Klin (Munich). 1996 Apr 12;91 Suppl 3:80-4. Review. German. No abstract available.
PMID:
8692125
Similar articles
Select item 8850099 307.
[Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid
gland?].
Schuppert F, Müller-Kunert E, Stöcker W, Bokemeyer C, Schmoll HJ, von zur Mühlen A,
Rambusch EG.
Med Klin (Munich). 1996 Feb 15;91(2):59-65. German.
PMID:
8850099
Similar articles
Select item 8554031 308.
A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal
cancer.
Erlichman C, Fine S, Kerr I, Hoffmann W, Gorg C, Schmoll HJ, Preusser P, Thuerlimann B,
Gustavsson B.
Am J Clin Oncol. 1996 Feb;19(1):26-31.
PMID:
8554031
Similar articles
Select item 9081388 309.
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Bokemeyer C, Beyer J, Metzner B, Ruther U, Harstrick A, Weissbach L, Kohrmann U,
Verbeek W, Schmoll HJ.
Ann Oncol. 1996 Jan;7(1):31-4.
PMID:
9081388
Similar articles
Select item 8958038 310.
Development of treatment for advanced colorectal cancer: infusional 5-FU and the role of
new agents.
Schmoll HJ.
Eur J Cancer. 1996;32A Suppl 5:S18-22. Review.
PMID:
8958038
Similar articles
Select item 8879254 311.
Treatment of clinical stage I testicular cancer and a possible role for new biological
prognostic parameters.
Bokemeyer C, Kuczyk MA, Serth J, Hartmann JT, Schmoll HJ, Jonas U, Kanz L.
J Cancer Res Clin Oncol. 1996;122(10):575-84. Review.
PMID:
8879254
Similar articles
Select item 8609154 312.
Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and
malignant germ-cell tumours.
Bokemeyer C, Kuczyk MA, Dunn T, Serth J, Hartmann K, Jonasson J, Pietsch T, Jonas U,
Schmoll HJ.
J Cancer Res Clin Oncol. 1996;122(5):301-6.
PMID:
8609154
Similar articles
Select item 8605273 313.
Hematopoietic growth factors and treatment of testicular cancer: biological interactions,
routine use and dose-intensive chemotherapy.
Bokemeyer C, Kuczyk MA, Köhne H, Einsele H, Kynast B, Schmoll HJ.
Ann Hematol. 1996 Jan;72(1):1-9. Review.
PMID:
8605273
Similar articles
Select item 8570137 314.
Evaluation of late nephrotoxicity in long-term survivors of Hodgkin's disease.
Fels LM, Bokemeyer C, van Rhee J, Schmoll HJ, Stolte H.
Oncology. 1996 Jan-Feb;53(1):73-8.
PMID:
8570137
Similar articles
Select item 8652248 315.
Secondary Raynaud's phenomenon and other late vascular complications following
chemotherapy for testicular cancer.
Berger CC, Bokemeyer C, Schneider M, Kuczyk MA, Schmoll HJ.
Eur J Cancer. 1995 Dec;31A(13-14):2229-38.
PMID:
8652248
Similar articles
Select item 8848861 316.
[Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ
cell tumor. Case report and clinical problems].
Kuczyk MA, Bokemeyer C, Fichna B, Truss M, Schmoll HJ, Jonas U.
Urologe A. 1995 Nov;34(6):480-4. German.
PMID:
8848861
Similar articles
Select item 8528750 317.
Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients.
Fischer B, Schmoll H, Riederer P, Bauer J, Platt D, Popa-Wagner A.
J Mol Med (Berl). 1995 Sep;73(9):465-71.
PMID:
8528750
Similar articles
Select item 21597787 318.
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and
discussion of the clinical implications.
Bokemeyer C, Kuczyk M, Fichna B, Jonas U, Poliwoda H, Schmoll H.
Oncol Rep. 1995 Jul;2(4):615-8.
PMID:
21597787
Similar articles
Select item 7573077 319.
High frequency of metalworkers among patients with seminomatous tumors of the testis: a
case-control study.
Rhomberg W, Schmoll HJ, Schneider B.
Am J Ind Med. 1995 Jul;28(1):79-87.
PMID:
7573077
Similar articles
Select item 7666466 320.
Risk of secondary leukemia following high cumulative doses of etoposide during
chemotherapy for testicular cancer.
Bokemeyer C, Schmoll HJ, Kuczyk MA, Beyer J, Siegert W.
J Natl Cancer Inst. 1995 Jan 4;87(1):58-60. No abstract available.
PMID:
7666466
Similar articles
321.
Antitumor-activity and toxicity of continuous-infusion versus bolus administration of
bleomycin in 2 heterotransplanted human testicular cancer cell-lines.
Bokemeyer C, Ludwig E, Reile D, Harstrick A, Poliwoda H, Schmoll H.
Oncol Rep. 1995 Jan;2(1):161-5.
PMID:
21597709
Similar articles
Select item 7828277 322.
No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular
carcinoma.
Bokemeyer C, Kynast B, Harstrick A, Laage E, Schmoll E, von Wussow P, Schmoll HJ.
Cancer Chemother Pharmacol. 1995;35(4):334-8.
PMID:
7828277
Similar articles
Select item 7799046 323.
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to
conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed
germ cell tumors: a randomized trial.
Bajorin DF, Nichols CR, Schmoll HJ, Kantoff PW, Bokemeyer C, Demetri GD, Einhorn LH,
Bosl GJ.
J Clin Oncol. 1995 Jan;13(1):79-86.
PMID:
7799046
Similar articles
Select item 7799032 324.
Treatment of testicular cancer and the development of secondary malignancies.
Bokemeyer C, Schmoll HJ.
J Clin Oncol. 1995 Jan;13(1):283-92. Review.
PMID:
7799032
Similar articles
Select item 7801148 325.
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell
tumors. German Testicular Cancer Study Group.
Bokemeyer C, Harstrick A, Rüther U, Metzner B, Illiger HJ, Clemm C, Siegert W, Link H,
Ostermann H, Schmoll HJ.
Semin Oncol. 1994 Dec;21(6 Suppl 16):57-63. Review.
PMID:
7801148
Similar articles
Select item 7526144 326.
[Rational therapy with G-CSF and GM-CSF].
Link H, Herrmann F, Welte K, Aulitzky WE, Ganser A, Kern WV, Meyer P, Schrappe M,
Schmoll HJ, Werdan K, et al.
Med Klin (Munich). 1994 Aug 15;89(8):429-41. Review. German. No abstract available.
PMID:
7526144
Similar articles
Select item 7924595 327.
[Adjuvant chemotherapy in rectal cancer].
Schmoll HJ.
Chirurg. 1994 Jul;65(7):576-84. Review. German.
PMID:
7924595
Similar articles
Select item 21567050 328.
5-ht3 antagonist ondansetron for the treatment of chemotherapy-induced nausea and vomiting
in an outpatient population.
Casper J, Casper S, Kohnewompner C, Bokemeyer C, Hecker H, Schmoll H.
Int J Oncol. 1994 Jun;4(6):1283-9.
PMID:
21567050
Similar articles
Select item 7919457 329.
Differential formation and enhanced removal of specific cisplatin-DNA adducts in two
cisplatin-selected resistant human testicular teratoma sublines.
Hill BT, Shellard SA, Fichtinger-Schepman AM, Schmoll HJ, Harstrick A.
Anticancer Drugs. 1994 Jun;5(3):321-8.
PMID:
7919457
Similar articles
Select item 7911158 330.
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous
stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The
German Testicular Cancer Cooperative Study Group.
Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R,
Bokemeyer C, Schmoll HJ, Huhn D.
J Clin Oncol. 1994 Jun;12(6):1223-31.
PMID:
7911158
Similar articles
Select item 8187625 331.
[Secondary leukemias after etoposide chemotherapy].
Bokemeyer C, Schmoll HJ, Poliwoda H.
Dtsch Med Wochenschr. 1994 May 13;119(19):707-13. Review. German. No abstract
available.
PMID:
8187625
Similar articles
Select item 8180015 332.
The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines
remains unaltered by the uroprotector mesna.
Bokemeyer C, Schmoll HJ, Ludwig E, Harstrick A, Dunn T, Casper J.
Br J Cancer. 1994 May;69(5):863-7.
PMID:
8180015
Free PMC Article
Similar articles
Select item 8167175 333.
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C, Schmoll HJ, van Rhee J, Kuczyk M, Schuppert F, Poliwoda H.
Ann Hematol. 1994 Mar;68(3):105-10.
PMID:
8167175
Similar articles
Select item 8313845 334.
[Stage-oriented therapy in nonseminomatous testicular tumors].
Derigs HG, Huber C, Schmoll HJ.
Dtsch Med Wochenschr. 1994 Feb 4;119(5):156-64. Review. German. No abstract available.
PMID:
8313845
Similar articles
Select item 7906255 335.
Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-
cancer cell lines differing in their sensitivity to standard agents.
Bokemeyer C, Dunn T, Harstrick A, Lerch T, Poliwoda H, Schmoll HJ.
Int J Cancer. 1994 Feb 1;56(3):452-6.
PMID:
7906255
Similar articles
Select item 8204538 336.
Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
Köhne-Wömpner CH, Schöffski P, Schmoll HJ.
Ann Oncol. 1994;5 Suppl 3:97-104. Review.
PMID:
8204538
Similar articles
Select item 8204526 337.
Colorectal carcinoma: current problems and future perspectives.
Schmoll HJ.
Ann Oncol. 1994;5 Suppl 3:115-21. Review.
PMID:
8204526
Similar articles
Select item 8080698 338.
The use of carboplatin in malignant germ cell tumours.
Bokemeyer C, Harstrick A, Schmoll HJ.
Eur J Cancer. 1994;30A(5):721-2. No abstract available.
PMID:
8080698
Similar articles
Select item 7820143 339.
Treatment intensification in disseminated germ-cell tumors.
Beyer J, Bokemeyer C, Schmoll HJ, Siegert W.
World J Urol. 1994;12(4):207-13. Review.
PMID:
7820143
Similar articles
Select item 7798304 340.
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-
refractory testicular cancer.
Bokemeyer C, Schmoll HJ, Natt F, Knoche M, Beyer J, Souchon R.
J Cancer Res Clin Oncol. 1994;120(12):754-7.
PMID:
7798304
Similar articles
341.
Treatment of adult osteosarcoma - single-center results in 47 patients.
Bokemeyer C, Schmoll H, Harstrick A, Kohnewompner H, Poliwoda H.
Int J Oncol. 1993 Nov;3(5):927-32.
PMID:
21573454
Similar articles
Select item 8411441 342.
Familial occurrence of Leydig cell tumors: a report of a case in a father and his adult son.
Bokemeyer C, Kuczyk M, Schöffski P, Schmoll HJ.
J Urol. 1993 Nov;150(5 Pt 1):1509-10. Review.
PMID:
8411441
Similar articles
Select item 8394879 343.
Secondary neoplasms following treatment of malignant germ cell tumors.
Bokemeyer C, Schmoll HJ.
J Clin Oncol. 1993 Sep;11(9):1703-9.
PMID:
8394879
Similar articles
Select item 8347733 344.
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified
chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular
cancer.
Bokemeyer C, Schmoll HJ, Metzner B, Beyer J, Illiger HJ, Kneba M, Ostermann H, Kynast
B, Räth U, Poliwoda H.
Ann Hematol. 1993 Aug;67(2):75-9.
PMID:
8347733
Similar articles
Select item 21573329 345.
No growth-stimulation of heterotransplanted human testicular cancer cell-lines by
recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf).
Bokemeyer C, Schmoll H, Casper J, Kuczyk M, Poliwoda H.
Int J Oncol. 1993 Jul;3(1):77-80.
PMID:
21573329
Similar articles
Select item 8508413 346.
Single-agent carboplatinum for advanced seminoma. A phase II study.
Schmoll HJ, Harstrick A, Bokemeyer C, Dieckmann KP, Clemm C, Berdel WE, Souchon R,
Schöber C, Wilke H, Poliwoda H.
Cancer. 1993 Jul 1;72(1):237-43.
PMID:
8508413
Free Article
Similar articles
Select item 8353097 347.
Secondary cancer following Hodgkin's disease.
Bokemeyer C, Lüer M, Schmoll HJ, Freund M, Poliwoda H.
Ann Oncol. 1993 Jun;4(6):520-1. No abstract available.
PMID:
8353097
Similar articles
Select item 8511834 348.
[Current developments in chemotherapy of advanced testicular tumors].
Schmoll HJ, Seeber S.
Urologe A. 1993 May;32(3):207-16. Review. German.
PMID:
8511834
Similar articles
Select item 21573603 349.
Phantom sensations after orchiectomy for testicular cancer.
Bokemeyer C, Frank B, Schoffski P, Poliwoda H, Schmoll H.
Int J Oncol. 1993 Apr;2(4):633-6.
PMID:
21573603
Similar articles
Select item 21573544 350.
Metastatic leydig-cell tumors of the testis - report of 4 cases and review of the literature.
Bokemeyer C, Harstrick A, Gonnermann O, Schober C, Kuczyk M, Poliwoda H, Schmoll H.
Int J Oncol. 1993 Feb;2(2):241-4.
PMID:
21573544
Similar articles
Select item 8499130 351.
Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma
cell lines.
Harstrick A, Schmoll HJ, Sass G, Poliwoda H, Rustum Y.
Eur J Cancer. 1993;29A(7):1000-2.
PMID:
8499130
Similar articles
Select item 8484987 352.
Side-effects of GM-CSF treatment in advanced testicular cancer.
Bokemeyer C, Schmoll HJ, Harstrick A.
Eur J Cancer. 1993;29A(6):924. No abstract available.
PMID:
8484987
Similar articles
Select item 8453702 353.
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy
for metastatic soft-tissue sarcoma in adults.
Harstrick A, Bokemeyer C, Schmoll HJ, Köhne-Wömpner CH, Knipp H, Schöffski P,
Anagnou J, Wipperman B, Neumann S, Poliwoda H.
Cancer Chemother Pharmacol. 1993;31 Suppl 2:S217-21.
PMID:
8453702
Similar articles
Select item 8394368 354.
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.
Grundner-Culemann E, Bokemeyer C, Neubauer V, Shalitin C, Schmoll HJ, Poliwoda H,
Benter T.
J Cancer Res Clin Oncol. 1993;119(11):685-8.
PMID:
8394368
Similar articles
Select item 8390363 355.
Treatment strategies in metastatic testicular cancer.
Bokemeyer C, Schmoll HJ.
Eur Urol. 1993;23 Suppl 2:50-2. No abstract available.
PMID:
8390363
Similar articles
Select item 8387319 356.
Bilateral testicular tumours: prevalence and clinical implications.
Bokemeyer C, Schmoll HJ, Schöffski P, Harstrick A, Bading M, Poliwoda H.
Eur J Cancer. 1993;29A(6):874-6.
PMID:
8387319
Similar articles
Select item 8386655 357.
Should high dose chemotherapy with, or without, autologous bone marrow transplant be
included in the primary treatment of testicular cancer? Round table discussion.
Grigor KM, Schmoll HJ.
Eur Urol. 1993;23(1):240-4.
PMID:
8386655
Similar articles
Select item 8386651 358.
How should we identify high risk testicular tumour patients? Round table discussion.
Grigor KM, Schmoll HJ.
Eur Urol. 1993;23(1):207-12.
PMID:
8386651
Similar articles
Select item 8384370 359.
Management of early stages of testicular carcinoma: the current status.
Schmoll HJ.
Recent Results Cancer Res. 1993;126:237-55. Review. No abstract available.
PMID:
8384370
Similar articles
Select item 8269588 360.
Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant
human testicular, ovarian, and gastric carcinoma cell lines.
Harstrick A, Bokemeyer C, Scharnofkse M, Hapke G, Reile D, Schmoll HJ.
Cancer Chemother Pharmacol. 1993;33(1):43-7.
PMID:
8269588
Similar articles
361.
5-Fluorouracil modulation in colorectal carcinoma experience of German investigators.
Kohne-Wompner CH, Schmoll HJ.
Adv Exp Med Biol. 1993;339:99-107. No abstract available.
PMID:
8178734
Similar articles
Select item 8178731 362.
Experience with 5FU + L-leucovorin.
Erlichman C, Fine S, Kerr I, Hoffman W, Gorg C, Schmoll HJ, Preusser P, Senn HJ,
Gustavsson B.
Adv Exp Med Biol. 1993;339:77-9; discussion 97-8. No abstract available.
PMID:
8178731
Similar articles
Select item 8110490 363.
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide
plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced
germ cell tumours.
Bokemeyer C, Schmoll HJ, Harstrick A, Illiger HJ, Metzner B, Räth U, Hohnloser J, Clemm
C, Berdel W, Siegert W, et al.
Eur J Cancer. 1993;29A(16):2225-31.
PMID:
8110490
Similar articles
Select item 8097467 364.
Treatment of advanced germ cell tumours by dose intensified chemotherapy with
haematopoietic growth factors or peripheral blood stem cells (PBSC).
Bokemeyer C, Schmoll HJ.
Eur Urol. 1993;23(1):223-9; discussion 230. Review.
PMID:
8097467
Similar articles
Select item 8095050 365.
Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast
cancer patients.
Kynast B, Binder L, Marx D, Zoll B, Schmoll HJ, Oellerich M, Schauer A.
J Cancer Res Clin Oncol. 1993;119(5):249-52.
PMID:
8095050
Similar articles
Select item 1281667 366.
Quality of life measurements in anti-emetic trials: a discussion of Professor Selby's paper.
Schmoll HJ.
Br J Cancer Suppl. 1992 Dec;19:S24-5.
PMID:
1281667
Free PMC Article
Similar articles
Select item 1538953 367.
Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced
germ cell tumors.
Schmoll HJ, Bokemeyer C, Harstrick A, Illiger HJ, Metzner B, Ruther U, Osternamm A,
Preiss J, Wilke H, Hohnloser J, et al.
Pathol Biol (Paris). 1992 Nov;39(9):961. No abstract available.
PMID:
1538953
Similar articles
Select item 1280461 368.
Secondary lymphoblastic leukemia following treatment of a malignant germ cell tumour.
Bokemeyer C, Freund M, Schmoll HJ, Rieder H, Fonatsch C.
Ann Oncol. 1992 Nov;3(9):772. No abstract available.
PMID:
1280461
Similar articles
Select item 1327710 369.
[Germ-cell tumors of the testis. The epidemiological and etiological aspects].
Bokemeyer C, Harstrick A, Schöffski P, Schmoll HJ, Poliwoda H.
Dtsch Med Wochenschr. 1992 Oct 2;117(40):1532-7. Review. German. No abstract available.
PMID:
1327710
Similar articles
Select item 1498067 370.
Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft
tissue sarcomas.
Bokemeyer C, Harstrick A, Schmoll HJ, Köhne-Wömpner CH, Schöffski P, Poliwoda H.
Ann Oncol. 1992 Jun;3(6):487-8.
PMID:
1498067
Similar articles
Select item 1557651 371.
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without
other cytostatic drugs in gastric, esophageal, and pancreatic cancer.
Wilke H, Stahl M, Schmoll HJ, Preusser P, Fink U, Meyer HJ, Achterrath W, Knipp H,
Köhne-Wömpner CH, Harstrick A, et al.
Semin Oncol. 1992 Apr;19(2 Suppl 3):215-9. Review.
PMID:
1557651
Similar articles
Select item 1557646 372.
Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced
colorectal cancer: preliminary results of a phase I/II trial.
Schmoll HJ, Köhne-Wömpner CH, Hiddemann W, Knipp H, Wilke H, Bodenstein H,
Schöffski P, Bokemeyer C, Lohrmann HP, Preiss J, et al.
Semin Oncol. 1992 Apr;19(2 Suppl 3):191-6.
PMID:
1557646
Similar articles
Select item 1557639 373.
A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer
and its impact in terms of palliation.
Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H.
Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40.
PMID:
1557639
Similar articles
Select item 1557638 374.
The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced
colorectal cancer.
Schöber C, Bokemeyer C, Stahl M, Wilke HJ, Schmoll HJ, Poliwoda H.
Semin Oncol. 1992 Apr;19(2 Suppl 3):131-5.
PMID:
1557638
Similar articles
Select item 1557636 375.
The emerging role for biomodulation of antineoplastic agents.
Schmoll HJ, Hiddemann W, Rustum Y, Köhne-Wömpner CH.
Semin Oncol. 1992 Apr;19(2 Suppl 3):1-3. No abstract available.
PMID:
1557636
Similar articles
Select item 1553577 376.
Cytokines and cytotoxic agents in renal cell carcinoma: a review.
Stahl M, Wilke HJ, Seeber S, Schmoll HJ.
Semin Oncol. 1992 Apr;19(2 Suppl 4):70-9. Review. No abstract available.
PMID:
1553577
Similar articles
Select item 1373004 377.
Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical
trials.
Köhne-Wömpner CH, Schmoll HJ, Harstrick A, Rustum YM.
Semin Oncol. 1992 Apr;19(2 Suppl 3):105-25. Review.
PMID:
1373004
Similar articles
Select item 1606089 378.
A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.
Stahl M, Wilke H, Schmoll HJ, Schöber C, Diedrich H, Casper J, Freund M, Poliwoda H.
Ann Oncol. 1992 Feb;3(2):167-8.
PMID:
1606089
Similar articles
Select item 1554799 379.
Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's
lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia
(PLL).
Freund M, Wunsch-Zeddies S, Schäfers M, Wysk J, Seidel I, Hiddemann W, Hanauske AR,
Link H, Schmoll HJ, Poliwoda H.
Ann Hematol. 1992 Feb;64(2):83-7.
PMID:
1554799
Similar articles
Select item 1314400 380.
[Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement].
Galanski M, Schmoll E, Reichelt S, Böhmer G, Prokop M, Schaefer C, Schüler A, Ringe B,
Schmidt FW, Schmoll HJ.
Radiologe. 1992 Feb;32(2):49-55. German.
PMID:
1314400
Similar articles
381.
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma
of the esophagus.
Harstrick A, Bokemeyer C, Preusser P, Köhne-Wömpner CH, Meyer HJ, Stahl M, Knipp H,
Schmoll HJ, Wilke H.
Cancer Chemother Pharmacol. 1992;29(4):321-2.
PMID:
1537080
Similar articles
Select item 1382494 382.
Antitumour effect and symptomatic control with interferon alpha 2b in patients with
endocrine active tumours.
Schöber C, Schmoll E, Schmoll HJ, Poliwoda H, Schuppert F, Stahl M, Bokemeyer C, Wilke
H, Weiss J.
Eur J Cancer. 1992;28A(10):1664-6.
PMID:
1382494
Similar articles
Select item 1665529 383.
[Therapy of a malignant sympathetic paraganglioma of the organ of Zuckerkandl--a case
report].
Schuppert F, Scheumann GF, Schöber C, Overbeck J, Schürmeyer TH, Schmoll HJ, Dralle H,
von zur Mühlen A.
Klin Wochenschr. 1991 Dec 11;69(20):937-42. German.
PMID:
1665529
Similar articles
Select item 1742217 384.
How should we treat disseminated seminoma?
Schmoll HJ.
Ann Oncol. 1991 Oct;2(9):623-4. No abstract available.
PMID:
1742217
Similar articles
Select item 1651992 385.
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell
carcinoma.
Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J,
Bruderek L, Schmoll E, Bokemeyer C, et al.
J Clin Oncol. 1991 Sep;9(9):1549-55.
PMID:
1651992
Similar articles
Select item 1714153 386.
[Modern therapeutic strategies in stomach cancer].
Wilke H, Preusser P, Fink U, Meyer HJ, Schmoll HJ, Stahl M, Seeber S.
Z Gastroenterol Verh. 1991 Mar;26:217-8. Review. German. No abstract available.
PMID:
1714153
Similar articles
Select item 1710481 387.
Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far
advanced testicular carcinoma.
Harstrick A, Schmoll HJ, Köhne-Wömpner CH, Bergmann L, Lammers U, Hohnloser J,
Dölken G, Reichhardt P, Siegert W, Natt F, et al.
Ann Oncol. 1991 Mar;2(3):197-202.
PMID:
1710481
Similar articles
Select item 1992534 388.
Megestrol acetate in cancer cachexia.
Schmoll E, Wilke H, Thole R, Preusser P, Wildfang I, Schmoll HJ.
Semin Oncol. 1991 Feb;18(1 Suppl 2):32-4.
PMID:
1992534
Similar articles
Select item 1831627 389.
Introduction: the clinical challenge.
Schmoll HJ.
Eur J Cancer. 1991;27 Suppl 1:S1-2.
PMID:
1831627
Similar articles
Select item 1742854 390.
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced
gastric cancer.
Wilke H, Preusser P, Stahl M, Harstrick A, Meyer HJ, Achterrath W, Schmoll HJ, Seeber S.
Cancer Chemother Pharmacol. 1991;29(1):83-4.
PMID:
1742854
Similar articles
Select item 1665492 391.
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant
granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular
carcinoma.
Harstrick A, Schmoll HJ, Bokemeyer C, Metzner B, Illiger HJ, Berdel W, Ostermann H,
Manegold C, Räth U, Siegert W, et al.
J Cancer Res Clin Oncol. 1991;117 Suppl 4:S198-202.
PMID:
1665492
Similar articles
Select item 2092872 392.
Modulation of cytotoxic drug activity by dipyridamole.
Schmoll HJ, Harstrick A, Köhne-Wömpner CH, Schöber C, Wilke H, Poliwoda H.
Cancer Treat Rev. 1990 Dec;17 Suppl A:57-65. Review. No abstract available.
PMID:
2092872
Similar articles
Select item 2283183 393.
Cellular oncogenes in human teratocarcinoma cell lines.
Tesch H, Fürbass R, Casper J, Lyons J, Bartram CR, Schmoll HJ, Bronson DL.
Int J Androl. 1990 Oct;13(5):377-88.
PMID:
2283183
Similar articles
Select item 2261377 394.
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II
study.
Harstrick A, Schmoll HJ, Wilke H, Schöber C, Stahl M, Wömpner CK, Bokemeyer C, Dölken
G, Burk K, Poliwoda H.
Ann Oncol. 1990 Sep;1(5):375-6.
PMID:
2261377
Similar articles
Select item 1695002 395.
[Phase II study with etoposide/vincristine in small cell bronchial cancer (extensive disease)].
von Pawel J, Wilke H, Vallée D, Dimbeck H, Schmoll HJ.
Pneumologie. 1990 Feb;44 Suppl 1:582-3. German.
PMID:
1695002
Similar articles
Select item 2312601 396.
Progress in treatment of testicular cancer.
Schmoll HJ.
J Cancer Res Clin Oncol. 1990;116(1):112-5. No abstract available.
PMID:
2312601
Similar articles
Select item 2148891 397.
Phase II study of carboplatin in untreated inoperable advanced stomach cancer.
Preusser P, Wilke H, Achterrath W, Lenaz L, Stahl M, Casper J, Meyer HJ, Meyer J, Blum
M, Schmoll HJ.
Eur J Cancer. 1990;26(10):1108-9. No abstract available.
PMID:
2148891
Similar articles
Select item 2145935 398.
Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with
different sensitivity to standard agents.
Harstrick A, Schmoll HJ, Casper J, Wilke H, Poliwoda H.
Eur J Cancer. 1990;26(8):898-901.
PMID:
2145935
Similar articles
Select item 2100702 399.
Significance of Tamm-Horsfall protein excretion in diabetes mellitus and cisplatin
nephrotoxicity.
Jäckle-Meyer I, Gwinner W, Baum M, Soose M, Petzoldt R, Schmoll HJ, Stolte H.
Contrib Nephrol. 1990;83:124-9. No abstract available.
PMID:
2100702
Similar articles
Select item 1696245 400.
Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines.
Harstrick A, Casper J, Köhne-Wömpner H, Wilke H, Schmoll HJ, Poliwoda H.
Invest New Drugs. 1990;8 Suppl 1:S19-24.
PMID:
1696245
Similar articles
401.
[Interdisciplinary therapy concepts in gastrointestinal tumors: stomach].
Meyer HJ, Jähne J, Pichlmayr R, Wilke H, Schmoll HJ, Poliwoda H.
Z Gastroenterol Verh. 1989 Jul;24:60-5. German. No abstract available.
PMID:
2474989
Similar articles
Select item 2660050 402.
[Results of treatment in primary disseminated osteosarcoma. Analysis of the follow-up of
patients in the cooperative osteosarcoma studies COSS-80 and COSS-82].
Winkler K, Torggler S, Beron G, Bode U, Gerein V, Jürgens H, Kusnierz-Glaz C, Kotz R,
Salzer-Kuntschik M, Schmoll HJ, et al.
Onkologie. 1989 Apr;12(2):92-6. German.
PMID:
2660050
Similar articles
Select item 2645036 403.
Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against
established human testicular cancer cell lines in vivo and in vitro.
Harstrick A, Casper J, Guba R, Wilke H, Poliwoda H, Schmoll HJ.
Cancer. 1989 Mar 15;63(6):1079-83.
PMID:
2645036
Free Article
Similar articles
Select item 2649987 404.
The role of ifosfamide in testicular cancer.
Schmoll HJ.
Semin Oncol. 1989 Feb;16(1 Suppl 3):82-95. Review.
PMID:
2649987
Similar articles
Select item 2539248 405.
Characterization of rearranged Y chromosomes in human testicular tumor cell lines.
Arnemann J, Gradl G, Casper J, Schmoll HJ, Schmidtke J, Fonatsch C.
Cancer Genet Cytogenet. 1989 Feb;37(2):141-51.
PMID:
2539248
Similar articles
Select item 2536606 406.
[Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin].
Bokemeyer B, Grote R, Schmoll E, Freise J, Schmoll HJ, Galanski M, Schüler A, Schmidt
FW.
Dtsch Med Wochenschr. 1989 Jan 27;114(4):128-32. German.
PMID:
2536606
Similar articles
Select item 2533897 407.
The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing
chemotherapy regimes.
Schmoll HJ.
Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S35-9. Review.
PMID:
2533897
Similar articles
Select item 2845770 408.
Etoposide and split-dose cisplatin in small-cell lung cancer.
Wilke H, Achterrath W, Schmoll HJ, Gunzer U, Preusser P, Lenaz L.
Am J Clin Oncol. 1988 Oct;11(5):572-8.
PMID:
2845770
Similar articles
Select item 3210656 409.
Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from
1981-1985.
Calavrezos A, Koschel G, Hüsselmann H, Taylessani A, Heilmann HP, Fabel H, Schmoll HJ,
Dietrich H, Hain E.
Klin Wochenschr. 1988 Jul 15;66(14):607-13.
PMID:
3210656
Similar articles
Select item 3044800 410.
Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus
VCMP.
Peest D, Deicher H, Coldewey R, Schmoll HJ, Schedel I.
Eur J Cancer Clin Oncol. 1988 Jun;24(6):1061-7.
PMID:
3044800
Similar articles
Select item 3356240 411.
VBAMDex chemotherapy in advanced multiple myeloma.
Peest D, Schmoll HJ, Schedel I, Glück S, Schumacher K, Deicher H.
Eur J Haematol. 1988 Mar;40(3):245-9.
PMID:
3356240
Similar articles
Select item 3204101 412.
Growth requirements, growth factor responsiveness, and growth factor secretion of three
human embryonal carcinoma cell lines.
Verbeek W, Bokemeyer C, Falk H, Schmoll HJ.
J Cancer Res Clin Oncol. 1988;114(6):553-8.
PMID:
3204101
Similar articles
Select item 3073658 413.
Folinic acid (CF)/5-fluorouracil (FUra) combinations in advanced gastrointestinal carcinomas.
Wilke H, Schmoll HJ, Preusser P, Fink U, Stahl M, Schöber C, Link H, Freund M, Hanauske
A, Meyer HJ, et al.
Adv Exp Med Biol. 1988;244:233-43. No abstract available.
PMID:
3073658
Similar articles
Select item 3064821 414.
Folinic acid (FA) plus 5-fluorouracil (FU) in progressive advanced colorectal cancer.
Wilke H, Schmoll HJ, Schöber C, Stahl M, Preusser P, Freund M, Poliwoda H.
Biomed Pharmacother. 1988;42(6):373-80. Review.
PMID:
3064821
Similar articles
Select item 2825966 415.
Lack of therapeutic activity of the lipoidal amine CP-46,665 in rodent tumors and human non-
seminomatous germ cell tumors growing in nude mice.
Berdel WE, Berger MR, Falk H, Harstrick A, Danhauser S, Schick HD, Schmoll HJ, Schmähl
D, Vogler WR, Rastetter J.
Cancer Lett. 1987 Dec;38(1-2):191-7.
PMID:
2825966
Similar articles
Select item 3626433 416.
[Low-dose alpha-interferon treatment of hairy cell leukemia].
von Wussow P, Freund M, Block B, Diedrich H, Schmoll H, Poliwoda H, Deicher H.
Klin Wochenschr. 1987 Jul 15;65(14):681-4. German.
PMID:
3626433
Similar articles
Select item 2436030 417.
[Raynaud syndrome and changes in lung function as sequelae of cytostatic therapy of
testicular tumors].
Creutzig A, Pölking W, Schmoll HJ, Fabel H, Alexander K.
Med Klin (Munich). 1987 Feb 27;82(4):131-4. German. No abstract available.
PMID:
2436030
Similar articles
Select item 3034790 418.
Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9
in human testicular carcinoma xenografts.
Harstrick A, Casper J, Schmoll HJ.
Int J Androl. 1987 Feb;10(1):139-45.
PMID:
3034790
Similar articles
Select item 3034787 419.
Cell lines of human germinal cancer.
Casper J, Schmoll HJ, Schnaidt U, Fonatsch C.
Int J Androl. 1987 Feb;10(1):105-13.
PMID:
3034787
Similar articles
Select item 2438224 420.
Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin
ultra high dose/VP-16/bleomycin.
Schmoll HJ, Schubert I, Arnold H, Dölken G, Hecht T, Bergmann L, Illiger J, Fink U, Preiss
J, Pfreundschuh M, et al.
Int J Androl. 1987 Feb;10(1):311-7.
PMID:
2438224
Similar articles
421.
Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cells.
Gabius HJ, Bokemeyer C, Hellmann T, Schmoll HJ.
J Cancer Res Clin Oncol. 1987;113(2):126-30.
PMID:
3031079
Similar articles
Select item 3528964 422.
Current results of a multicenter trial in multiple myeloma.
Peest D, Schmoll HJ, Schedel I, Deicher H, Boll J, Essers U, Gamm H, Glück S, Görg K,
Gramatzki M, et al.
Onkologie. 1986 Jun;9(3):168-9.
PMID:
3528964
Similar articles
Select item 3010437 423.
Comparison of endogenous lectins in human embryonic carcinoma and yolk sac carcinoma.
Gabius HJ, Engelhardt R, Casper J, Schmoll HJ, Nagel GA, Cramer F.
Tumour Biol. 1986;6(5):471-82.
PMID:
3010437
Similar articles
Select item 4048775 424.
Cell surface lectins of transplantable human teratocarcinoma cells: purification of a new
mannan-specific endogenous lectin.
Gabius HJ, Engelhardt R, Casper J, Reile D, Schumacher S, Schmoll HJ, Graupner G, Cramer
F.
Tumour Biol. 1985;6(2):145-56.
PMID:
4048775
Similar articles
Select item 6431531 425.
[Exposure technics for computed scintigrams].
Klose E, Ritter EP, Massopust D, Endert G, Schumann E, Hasse P, Schmoll H, Beyer HK.
Rofo. 1984 Jul;141(1):97-9. German.
PMID:
6431531
Similar articles
Select item 6192987 426.
[Chemotherapy in pretreated Hodgkin's disease with lomustine, bleomycin, vinblastine and
dexamethasone].
Weiss J, von Roemeling R, Peters HD, Schmoll HJ, Diehl V.
Dtsch Med Wochenschr. 1983 Sep 23;108(38):1428-32. German.
PMID:
6192987
Similar articles
Select item 6383688 427.
Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer
treatment.
Hacke M, Schmoll HJ, Alt JM, Baumann K, Stolte H.
Clin Physiol Biochem. 1983;1(1):17-26.
PMID:
6383688
Similar articles
Select item 6890331 428.
Pharmacokinetics of liposome encapsulated cisplatin in rats.
Freise J, Mueller WH, Magerstedt P, Schmoll HJ.
Arch Int Pharmacodyn Ther. 1982 Aug;258(2):180-92.
PMID:
6890331
Similar articles
Select item 6751532 429.
Review of etoposide single-agent activity.
Schmoll H.
Cancer Treat Rev. 1982 Jun;9 Suppl:21-30. Review. No abstract available.
PMID:
6751532
Similar articles
Select item 7108259 430.
[Role of lymphadenectomy in stages I and II of non-seminoma tumors. Report of their
modern chemotherapy (author's transl)].
Schindler E, Waegner W, Schmoll H, Zockler H.
J Urol (Paris). 1982;88(5):295-9. French. No abstract available.
PMID:
7108259
Similar articles
Select item 7031350 431.
[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's
transl)].
Schmoll HJ, Niederle N, Achterrath W.
Klin Wochenschr. 1981 Nov 2;59(21):1177-88. German.
PMID:
7031350
Similar articles
Select item 462206 432.
Motivation to participate in cancer screening programmes.
Schwoon DR, Schmoll HJ.
Soc Sci Med. 1979 May;13A(3):283-6. No abstract available.
PMID:
462206
Similar articles
Select item 4494385 433.
[The migrant worker as patient].
Schmoll HJ.
Schwest Rev. 1974 Apr 15;12(4):25-6. German. No abstract available.
PMID:
4494385
Similar articles
Select item 4801695 434.
[Disease statistics of foreign workers (author's transl)].
Schmoll HJ.
Munch Med Wochenschr. 1973 Dec 14;115(50):2280-4. German. No abstract available.
PMID:
4801695
Similar articles
Select item 4271515 435.
[A social and medical contribution to the discussion on the state of health among foreign
workers (author's transl)].
Collatz J, Schmoll HJ.
Offentl Gesundheitswes. 1973 Aug;35(8):449-58. German. No abstract available.
PMID:
4271515
Similar articles